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The association of Merkel cell polyomavirus (MCPyV) and Merkel cell carcinoma (MCC) established in
2008 has opened doors for the study of virus-induced oncogenesis. Much of what is known about
polyomaviruses (PyVs) stems from decades of studies on SV40. However, recent research has shown
differences among PyVs that might help explain the uniqueness of MCPyV that makes it the only PyV
discovered to date that is associated with a human cancer. Therefore, it is important to understand the biology
of this virus and its oncogenic potential.
My study focuses on two of the early proteins of MCPyV, namely the large tumor antigen (LT) and the small
tumor antigen (sT). Both proteins are multi-functional, contributing to viral replication and the stimulation of
cellular proliferation. MCPyV LT is the viral helicase that binds to the viral origin (Ori) to initiate unwinding
and the replication of the double-stranded DNA genome. Like other PyVs, MCPyV requires numerous
cellular proteins to replicate its genome. In my research, I show that, in the presence of the viral Ori, the
binding of LT to the Ori forms replication factories in the nucleus. A number of cellular factors involved in the
host DNA damage response (DDR) re-localize to the sites of MCPyV LT-mediated replication. Inhibition of
the DNA damage response by either drug treatment or siRNA knockdown decreases MCPyV replication,
suggesting that an intact host DDR pathway is essential for the optimal replication of MCPyV.
Previous research has shown that MCPyV sT indirectly enhances viral replication by stabilizing LT. In my
study, I discover that sT is a metalloprotein that coordinates two iron-sulfur clusters. Mutations in the highly
conserved cysteines found in MCPyV sTs abolishes its ability to stimulate LT-mediated viral DNA replication,
and that sT can enhance LT-mediated replication in a manner that is independent of LT stabilization.
Moreover, I show that sT translocates to the nuclear replication factories formed in the presence of LT and
Ori, suggesting a more direct role of sT in promoting viral DNA replication. Interestingly, upon treatment
with the potent antiviral agent cidofovir, sT-mediated enhancement of MCPyV replication is robustly
inhibited, while replication driven by LT alone was not affected much. This finding supports the use of
cidofovir in controlling PyV infection and offers MCPyV sT as a potential drug target to dampen viral growth.
In summary, my work elucidates various aspects of MCPyV replication, including the involvement of the host
DDR machinery and the role of sT that could potentially be targeted by drug treatment. This study
contributes to the understanding of the virology of MCPyV and opens avenues for further research.
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ABSTRACT 
 
INSIGHT INTO MERKEL CELL POLYOMAVIRUS REPLICATION 
THROUGH THE STUDY OF THE VIRAL EARLY PROTEINS:  
LARGE AND SMALL TUMOR ANTIGENS 
Sabrina H. Tsang 
Dr. Jianxin You 
 The association of Merkel cell polyomavirus (MCPyV) and Merkel cell 
carcinoma (MCC) established in 2008 has opened doors for the study of virus-induced 
oncogenesis. Much of what is known about polyomaviruses (PyVs) stems from decades 
of studies on SV40. However, recent research has shown differences among PyVs that 
might help explain the uniqueness of MCPyV that makes it the only PyV discovered to 
date that is associated with a human cancer. Therefore, it is important to understand the 
biology of this virus and its oncogenic potential. 
 My study focuses on two of the early proteins of MCPyV, namely the large tumor 
antigen (LT) and the small tumor antigen (sT). Both proteins are multi-functional, 
contributing to viral replication and the stimulation of cellular proliferation. MCPyV LT 
is the viral helicase that binds to the viral origin (Ori) to initiate unwinding and the 
replication of the double-stranded DNA genome. Like other PyVs, MCPyV requires 
numerous cellular proteins to replicate its genome. In my research, I show that, in the 
presence of the viral Ori, the binding of LT to the Ori forms replication factories in the 
nucleus. A number of cellular factors involved in the host DNA damage response (DDR) 
re-localize to the sites of MCPyV LT-mediated replication. Inhibition of the DNA 
	   vii	  
damage response by either drug treatment or siRNA knockdown decreases MCPyV 
replication, suggesting that an intact host DDR pathway is essential for the optimal 
replication of MCPyV. 
 Previous research has shown that MCPyV sT indirectly enhances viral replication 
by stabilizing LT. In my study, I discover that sT is a metalloprotein that coordinates two 
iron-sulfur clusters. Mutations in the highly conserved cysteines found in MCPyV sTs 
abolishes its ability to stimulate LT-mediated viral DNA replication, and that sT can 
enhance LT-mediated replication in a manner that is independent of LT stabilization. 
Moreover, I show that sT translocates to the nuclear replication factories formed in the 
presence of LT and Ori, suggesting a more direct role of sT in promoting viral DNA 
replication. Interestingly, upon treatment with the potent antiviral agent cidofovir, sT-
mediated enhancement of MCPyV replication is robustly inhibited, while replication 
driven by LT alone was not affected much. This finding supports the use of cidofovir in 
controlling PyV infection and offers MCPyV sT as a potential drug target to dampen viral 
growth. 
 In summary, my work elucidates various aspects of MCPyV replication, including 
the involvement of the host DDR machinery and the role of sT that could potentially be 
targeted by drug treatment. This study contributes to the understanding of the virology of 
MCPyV and opens avenues for further research. 
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CHAPTER 1: INTRODUCTION 
 
1.1: Merkel Cell Carcinoma and the Discovery of Merkel Cell Polyomavirus  
1.1.1: Merkel cell carcinoma 
 The first description of Merkel cell carcinoma (MCC) was published in 1972 by 
Cyril Toker (1). MCC is a rare but highly aggressive human skin cancer that is typically 
associated with immunosuppression. Excessive UV exposure and advanced age are also 
considered principle risk factors for MCC (2). Recent studies have shown that MCC 
incidence has tripled in the past two decades (3, 4). Although rare, the mortality rate of 
MCC is as high as 30% (4). While it is thought that MCC originates from the 
transformation of Merkel cells, which are skin cells found in the basal layer of the 
epidermis and in hair follicles that have both epithelial and neurosecretory characteristics 
and are responsible for transmitting fine touch sensation (5), the oncogenesis of MCC 
remained unclear.  
1.1.2: Discovery of Merkel cell polyomavirus 
 The association of MCC with immunosuppression suggests an infectious origin. 
In 2008, Yuan Chang and Patrick Moore’s group utilized digital transcriptome 
subtraction (DTS) to search for potential viral sequences associated with MCC. They 
generated and sequenced cDNA libraries from MCC specimens. Transcripts that were 
aligned to human sequences were then subtracted to generate the databases with potential 
viral sequences. Ultimately, they identified two sequences, one of which was aligned to 
African green monkey lymphotropic polyomavirus with high homology (6). Subsequent 
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rapid amplification of cDNA ends (3’-RACE) discovered that the viral genome was in 
fact stably and clonally integrated into the MCC genome. Of note, of the ten MCC tumor 
samples tested, eight were positive for the viral sequences. The Chang/Moore group then 
named this new virus Merkel cell polyomavirus (MCPyV). Subsequent studies have 
confirmed the presence of integrated MCPyV in MCC and improved detection methods 
have shown that 97% of MCC is associated with MCPyV (7). In fact, the World Health 
Organization’s International Agency for Research on Cancer has now classified MCPyV 
as a group 2A carcinogen, meaning it is “probably carcinogenic to humans” (8). 
 
1.2: Merkel Cell Polyomavirus Virology 
1.2.1: Merkel cell polyomavirus genome organization 
 Like other polyomaviruses, MCPyV has a circular, double-stranded DNA genome 
of about 5.4 kilobases (9). The early region encodes the large tumor (LT) antigen, the 
small tumor (sT) antigen, 57kT antigen, and a recently discovered protein named 
Alternate frame of the Large T Open reading frame (ALTO) (10) (also see Fig. 1.1). The 
late region encodes the viral capsid proteins VP1 and VP2. The early and late regions are 
separated by the non-coding regulatory region (NCRR), which contains the viral 
replication origin (Ori) and the promoters for the bidirectional transcription of the early 
and late genes. The sequential expression of early and late genes serves as a temporal 
regulation for the viral life cycle, a common scheme seen with other DNA viruses (11). 
Immediately upon viral entry into the host cell, T antigens are expressed to initiate 
replication of the viral DNA genome. With the onset of viral replication, the late region is 
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activated and structural components of the icosohedral capsid are then expressed to 
produce the new progeny of virions.  
 
 
 
Figure 1.1   Organization of the MCPyV genome. MCPyV has a dsDNA genome of 
~5.4 kilobases. The non-coding regulatory region (NCRR) contains the viral replication 
origin and the promoters for the transcription of early and late genes. The early region 
encodes LT, sT, 57kT, and ALTO. The late region encodes the capsid proteins VP1 and 
VP2. The MCPyV miRNA downregulates LT expression to dampen viral repliation. 
Schematic is provided by courtesy of Dr. Wei Liu from our lab.  
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1.2.2: Merkel cell polyomavirus large tumor antigen 
 The MCPyV early region spans about three-fifths of the viral genome. Generally, 
to generate an environment conducive for viral replication, the early gene products of 
polyomavirus target cellular proteins that are involved in regulating the host cell cycle 
and in tumor suppression (12-15). MCPyV LT antigen of 816 amino acids, the largest of 
the early proteins, consists of a number of domains important for its functions. The N-
terminus of LT has a CR1 (LXXLL) and a DnaJ (HPDKGG) domain that are responsible 
for Hsc70 binding (16, 17), which is important for MCPyV replication in vitro (18). 
 Amino acids ~100-300 of MCPyV LT contains a conserved Rb-binding (LXCXE) 
motif and the nuclear localization signal (NLS) (19). Interestingly, this stretch of 
sequences shares little homology to other polyomaviruses. The region, named by the 
Chang/Moore group as the MCPyV T antigen unique region (MUR), interacts with the 
vacuolar sorting protein Vam6p, resulting in the nuclear sequestration of Vam6p and the 
disruption of lysosomal clustering (20). Moreover, in an in vitro replication assay, it was 
shown that the loss of LT-Vam6p binding leads to enhanced viral replication (11). While 
the mechanism by which Vam6p regulates MCPyV replication is not understood, it is 
possible that the LT-Vam6p interaction inhibits viral reaction and helps establish latency 
in the host cell. It has been proposed that the prototypical polyomavirus simian virus 
(SV40) miRNA inhibits SV40 LT expression, serving as an autoregulatory mechanism 
(21). In fact, MCPyV encodes a 22-nucleotide miRNA (MCPyV-miR-M1-5p) that 
function like Vam6p and dampen viral replication (22, 23). Besides its interaction with 
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Vam6p, how the MUR contributes to the uniqueness of MCPyV biology requires further 
investigation.  
 MCPyV LT contains the LXCXE motif, which mediates the binding to the tumor 
suppressor Rb (17, 24). The interaction between LT and Rb is phenotypically conserved 
across polyomaviruses and is essential for dysregulating E2F-mediated transcription and 
driving the cells into S phase (25). E2F target genes are upregulated upon the binding of 
MCPyV LT to Rb (19, 26). It has been shown that the complementation with an Rb-
binding LT mutant is not able to rescue MCC cell growth upon RNA-depletion of the T 
antigen in the MCC cells, suggesting that an intact LXCXE motif is important for MCC 
tumor survival (27). Moreover, it was found that an intact Rb-binding motif is associated 
with the upregulation of an anti-apoptotic protein called survivin (26), which is thought to 
be a therapeutic option since in vivo studies have shown that survivin inhibitor can 
lengthen the survival of mice with MCC xenografts (26, 28). 
 The C-terminal half of MCPyV LT contains regions that are essential for viral 
replication. The origin binding domain (OBD) on LT mediates the recognition and 
binding to the minimum 71-bp Ori in the NCRR (29). Previous work from our lab has 
identified two phosphorylation sites on LT that regulate LT’s ability to initiate 
replication: Threonine 297 phosphorylation inhibits LT binding to the Ori, while 
threonine 299 phosphorylation is required to stimulate LT-mediated replication (30). The 
helicase/ATPase domain resides in amino acid 441-817 of LT, and it is important for the 
oligomerization of LT at the Ori and the initiation of replication (25).  
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Additionally, the helicase domain in SV40 LT contains a bipartite sequence that 
binds to the tumor suppressor p53, resulting in the inhibition of its target genes’ 
transcription and the bypass of senescence or apoptosis (16, 25, 31-33). However, 
currently there is no published evidence to show that MCPyV LT directly binds to p53 
(24, 34). In effort to test for LT-p53 binding, I have unpublished data showing that 
MCPyV LT could co-immunoprecipitate with p53 in HEK293 cells. Unfortunately, this 
interaction was not detected in two other cell lines that were tested, namely cervical 
cancer cells C33A and the osteosarcoma cells U2OS. It is possible that LT-p53 
interaction is cell-type specific. Therefore, it has yet to be tested whether LT interacts 
with p53 in the natural host cell of MCPyV, which remains to be identified and is an 
ongoing investigation in our lab.  
 The most striking feature of MCPyV LT found in MCC is that the C-terminal half 
important for viral replication is truncated, while the N-terminal half responsible for Rb 
binding is intact (17, 35), suggesting that there is a selective pressure for the elimination 
of viral replication when the viral genome is integrated into the host genome. It is 
hypothesized that unlicensed replication of the integrated viral genome would lead to 
replication-fork collisions, DNA strand breaks, and, ultimately, cell death (9). In fact, the 
lack of viral replication competency is a common theme among integrated tumor viruses 
(36-38). Work from our lab supports this hypothesis, because we found that the MCPyV 
LT helicase domain is responsible for inducing the host DDR and subsequent p53-
mediated cell cycle arrest (39). We have also identified that the phosphorylation of 
MCPyV LT at serine 816 by a DDR kinase induces apoptosis in host cells (40). In 
addition, another group has reported that the expression of the last 100 residues in the C-
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terminus of MCPyV LT alone is enough to slow down the growth of an established MCC 
cell line and in human fibroblasts immortalized by SV40 (34). In summary, all the 
findings support the notion that the C-terminal half of MCPyV LT has anti-proliferative 
function and, therefore, must be eliminated for oncogenesis to occur. 
1.2.3: Merkel cell polyomavirus small tumor antigen 
 Another MCPyV early protein is called small tumor antigen (sT), which shares 
the first N-terminal 78 amino acids with LT. This 186-amino acid protein is thought to 
play a more critical role in oncogenesis than LT. Unlike other polyomaviruses, MCPyV 
sT expression alone is sufficient to transform rodent fibroblasts in vitro (41), and is 
required for MCC proliferation (42). Furthermore, it has been shown that MCPyV sT has 
proliferative effect in a transgenic mice model (43). MCPyV sT has a unique C-terminus 
that contains a protein phosphatase 2A (PP2A) binding site. The ability to bind PP2A is 
phenotypically conserved across polyomavirus sT proteins and this sT-PP2A interaction 
has been shown to be important for cellular transformation by other polyomaviruses (12). 
SV40 sT, for example, binds and inhibits PP2A, preventing it from dephosphorylating 
Akt, rendering it constitutively active (44-46). Although MCPyV sT interacts with PP2A, 
it can promote sustained phosphorylation of the translation factor eIF4E binding protein 1 
(4E-BP1), consequently leading to cap-dependent translation independent of binding to 
PP2A (41).  
Using mass spectrometry, it was discovered that MCPyV sT not only binds to 
PP2A subunits but also PP4C (47). The sT-PP4C interaction contributes to the targeting 
of the NF-κB essential modulator (NEMO), consequently preventing the nuclear 
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translocation of NF-κB and disrupting the host cell’s inflammatory signaling that is 
dependent on NF-κB-mediated transcription (47). In addition, sT-PP4C binding is found 
to induce the destabilization of microtubules via dysregulated phosphorylation of 
stathemin (48). The resulting phenotype increases cell migration and invasion and it is 
thought to contribute to the highly metastatic nature of MCC (48). 
In addition to its role in transformation, MCPyV sT has been shown to promote 
viral replication (11, 18). The Chang/Moore group has shown that sT can indirectly 
stabilize LT protein level by inhibiting the E3 ubiquitin ligase SCFFbw7, which targets LT 
for degradation and negatively regulates MCPyV replication (49). MCPyV sT also 
stabilizes other SCFFbw7 substrates, such as c-Myc and cyclin E, and contribute to cellular 
transformation (49). The inhibition of SCFFbw7 has been mapped to amino acids 91-95 on 
MCPyV sT, which is referred to as the LT-stabilization domain (LSD). It has been shown 
that the LSD on sT is essential for its in vitro (49) and in vivo (43) transformation 
activity. 
1.2.4: Other viral early proteins 
 The two other early proteins of MCPyV, namely 57kT and ALTO, are less well 
studied. 57kT is a 432-amino acid product from alternative splicing of the T antigen, and 
it shares with LT the CR1 and DnaJ domain, the MUR, the Rb-binding motif, and the last 
100 amino acids in the C-terminus. It is often compared to SV40’s 17kT, which functions 
independently and in cooperation with other early proteins to control cellular 
proliferation (50-52).  
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 ALTO was discovered as an overprinting gene expressed from a cryptic reading 
frame within the T antigen locus (10). It is phylogenetically related to the middle T 
antigen of murine polyomavirus. Although this protein is expressed during the MCPyV 
replication, it is not required for the process (10). The role of ALTO in MCPyV life cycle 
remains to be investigated.  
1.2.5: Merkel cell polyomavirus late proteins 
 The late region of the MCPyV genome carries open reading frames for the major 
capsid protein VP1 and VP2. Although there is a third open reading frame for the capsid 
protein VP3, this protein is either non-functional or is not expressed in natural MCPyV 
infection (53, 54). The expression of VP1 alone is sufficient for the production of virus-
like particles (VLPs) of ~40-55 nm in size but the presence of VP2 is required for 
efficient infection in vitro (54-56). 
 The cellular receptor for MCPyV was first thought to be the sialic acid 
components of the ganglioside Gt1b, similar to other polyomaviruses (57, 58). However, 
later studies have revealed that MCPyV pesudovirions (composed of VP1, VP2, and a 
luciferase reporter plasmid) requires sulfated glycosaminoglycans, particularly heparan 
sulfate, for viral entry (56). Subsequent report on the crystal structure of VP1 supports the 
notion that MCPyV uses glycosaminoglycans as the primary attachment factor but 
requires a sialylated glygan as an internalization factor (59). This two-step entry process 
is unique for MCPyV, once again highlighting the importance of studying the difference 
between MCPyV and other polyomavirues.  
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1.3: Host DNA Damage Response and Viral Replication 
1.3.1: Host DNA damage response 
 Like many other DNA viruses, polyomaviruses require numerous host factors to 
replicate their genomes. Besides the usual machinery utilized in cellular replication, 
factors involved in the host’s DDR are often hijacked in order for efficient and successful 
viral replication to occur. For us to investigate how viruses could exploit the cellular 
machinery for their own use, we must first understand the role of the host DDR factors in 
maintaining genomic stability.  
 DNA lesions arise from endogenous and exogenous DNA damage. Endogenous 
DNA damage includes spontaneous misincorporation of nucleotides during DNA 
replication, interconversion between DNA bases caused by deamination, loss of DNA 
bases upon DNA depurination, and DNA breaks generated by reactive oxygen species 
derived from normal metabolism (60). Exogenous DNA damage include physical 
genotoxic agents such as ionizing radiation (IR) and ultraviolet (UV) light, and chemical 
agents such as drugs used in cancer chemotherapy (61). 
 To cope with DNA damage, cellular repair mechanisms tailored for different 
types of DNA lesion are in place to maintain genomic integrity. While mispaired DNA 
bases are corrected by mismatch repair (MMR), small chemical alterations of DNA bases 
are repaired by base excision repair (BER) (62). Pyrimidine dimers and intrastand 
crosslinks are fixed by nucleotide excision repair (NER) (61). Single-stranded DNA 
(ssDNA) breaks (SSBs) are corrected by single-strand break repair (SSBR); double-
stranded DNA (dsDNA) breaks (DSBs) are repaired by either non-homologous end 
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joining (NHEJ) or homologous recombination (HR), with HR being a more reliable 
mechanism due to the use of sister chromatids as template for repair (63, 64). Efficient 
DDR requires timely recognition of the DNA lesions and appropriate coordination of the 
repair factors in the pathways employed.  
 The DDR is mediated by proteins of the phosphatidylinositol 3-kinase (PI3K)-like 
protein kinase (PIKKs) family, namely the ataxia telangiectasia mutated (ATM) and 
ATM- and Rad3-related (ATR) kinases and the DNA-dependent protein kinase (DNA-
PK). While DSBs activates both ATM and DNA-PK (65, 66), RPA-coated ssDNA 
regions at stalled replication forks and at DSBs activate ATR (67). The proteins in the 
poly(ADP-ribose) polymerase (PARP) family, mainly PARP1 and PARP2, are also 
implicated in DDR. They are activated by both SSBs and DSBs and they help recruit 
DDR factors to the sites of damage (68). 
 The presence of DSBs in the genome activates PARP1, which recruits the 
heterotrimeric Mre11-Rad50-Nbs1 (MRN) complex and ATM to the lesion. MRN 
induces the auto-phosphorylation and activation of ATM (69). Activated ATM, in turn, 
phosphorylates the histone variant H2AX (70), the downstream kinase Chk2, and p53, 
resulting in cell cycle arrest, senescence, or apoptosis (71). In parallel, DNA breaks 
generated by stalled replication forks lead to the accumulation of RPA-coated ssDNA 
regions on the genome, which in turn recruit the Rad17/RFC2-5 complex, ATR, and its 
interacting partner ATRIP to the site of lesion (67). The Rad17/RFC2-5-mediated loading 
of the 9-1-1 complex and the stimulation from the 9-1-1-associated protein TOPBP1 
consequently lead to the activation of ATR. Activated ATR phosphorylates H2AX and 
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the Chk1 kinase, which shares a number of downstream targets with Chk2, leading to cell 
cycle delay for the restoration of replication fork stability (67). Depending on the type 
and the severity of the damage, previous research has shown significant amount of 
crosstalk between the ATM and ATR pathways (60, 72-75).  
1.3.2: Viral manipulation of the host DNA damage response 
There are numerous reviews on viral manipulation of the host DDR in the 
literature (76-80). It is well known that viral infections, including both DNA and RNA 
viruses, often introduce chromosomal aberrations in the host cell, and it is established 
that genome instability is a hallmark of cancer (81). It then becomes important for us to 
understand if and how viruses utilize the host DDR for the completion of their life cycles, 
and how such manipulations could potentially contribute to oncogenesis. In this part of 
the chapter, two tumor viruses, namely human papillomaviruses (HPV) and Epstein-Barr 
virus (EBV), and their relationships with the host DDR will be discussed to serve as 
examples of viral manipulation of the host’s repair pathways. 
HPV has been one of the research interests in our lab due to its association with 
cervical cancer and other anogenital and oropharynal malignancies (82). Similar to 
MCPyV-associated MCC, the HPV viral genome is often found integrated into the 
genome of HPV-associated cancer cells (83). It was found that expression of the viral 
helicase E1 can activate the ATM (84) and ATR pathway (85), and that the DDR 
activation is attributed to the E1-induced generation of DSBs on cellular DNA (86). 
Moreover, the presence of integrated HPV genome can lead to unscheduled DNA 
replication, consequently activating the host DDR (38, 87). Various DDR factors have 
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also been found associated with the HPV replication centers (86-88), suggesting that they 
play a role in HPV replication. However, the underlying mechanism is not well 
understood. Interestingly, despite the activation of the host DDR, the viral proteins E6 
and E7 dysregulate the repair pathways to bypass cell cycle arrest and the apoptotic 
response in order to promote cellular proliferation (89, 90). 
EBV is associated with Burkitt’s lymphoma, Hodgkin’s lymphoma, 
nasopharyngeal carcinoma and gastric carcinoma (91). It was noted that EBV-infected 
Burkitt’s lymphoma cell lines have increased chromosomal abnormalities (92). During 
latency, the expression of the EBV nuclear antigen 1 (EBNA-1) induces DSBs through 
the production of reactive oxygen species (93). During lytic replication in B cells, EBV 
activates the ATM pathway (94). The importance of the host DDR in EBV replication 
remains debatable but it was found that a number of factors involved in HR, such as 
RPA, Rad51 and Rad52, have been found to localize at EBV replication compartments, 
and the knockdown of RPA and Rad51 significantly reduced viral replication (95, 96).  
Extensive reviews on viral manipulation of the host DDR have suggested a strong 
association between viral replication and the activation of DDR. Although the exact 
mechanisms by which the DDR factors contribute to viral replication remain a question 
of interest, the importance of the host repair pathways is undeniable. In the following 
section of this chapter, I will focus the discussion on polyomavirus replication and the 
connection between MCPyV and the host DDR.  
1.3.3: Merkel cell polyomavirus replication 
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 SV40 has long been the model for understanding eukaryotic replication (97). The 
SV40 Ori within the NCRR contains a number of GAGGC pentanucleotide repeats which 
allow for LT binding through the OBD (97). Upon binding to the Ori, SV40 LT 
oligomerizes to form hexamers for the initiation of replication (98, 99). The helicase 
domain on LT contains an ATPase domain important for unwinding of the viral DNA 
(100-102). Other celluar replication factors, including RPA70, RFC1, and DNA 
polymerase α, δ, ε, are subsequently recruited to the Ori to mediate viral replication (97, 
103).  
 MCPyV replication is comparable to SV40’s. Even though MCPyV LT is the 
only viral protein required for viral replication, the co-expression of sT significantly 
boosts replication, and such phenotype is attributed to sT’s ability to stablize LT protein 
level (18, 49). Previously, our lab has set up a system in cultured cells to study MCPyV 
replication. We found that MCPyV LT can recruit the host protein BRD4 to viral 
replication factories, which then recruits RFC1, an important factor for the loading of 
proliferating cell nuclear antigen (PCNA) clamp onto DNA and for the recruitment of 
DNA polymerases to the site of replication (104). This system serves a platform for my 
study on MCPyV replication (see below).  
 It has been well documented that polyomavirus infection or ectopic expression of 
polyomavirus T antigens can activate the host DDR (39, 105-111). Of note, previous 
study from our lab has shown that MCPyV LT expression alone can elicit a robust DDR, 
and this ability of LT to stimulate the DDR is mapped to the C-terminal helicase domain 
(39). On the other hand, there is accumulating evidence to show that the host DDR 
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machinery is used for polyomavirus replication. For example, ATM-mediated 
phosphorylation of SV40 LT is essential for its ability to initiate viral replication (112). 
Moreover, reports on JC polyomavirus (JCPyV) and BK polyomavirus (BKPyV) show 
activation of the ATM and ATR pathways upon viral infection, and that their activation is 
important for viral genome amplification and virion production (108, 109). Collectively, 
these findings strongly suggest a potential role of the host DDR in MCPyV replication. 
However, direct evidence of DDR machinery contributing to MCPyV replication has not 
yet been shown. In Chapter 2 of my thesis, I present my data showing that an intact host 
DDR pathway is essential for optimal MCPyV replication. 
 
1.4: Iron-Sulfur Cluster Proteins and their Roles in Replication  
1.4.1: Iron-sulfur cluster proteins 
 As mentioned before, the co-expression of LT and sT significantly boost MCPyV 
replication (18, 49). Therefore, I set out to investigate the function of sT in viral 
replication. Serendipitiously, I discovered that sT is a novel iron-sulfur (Fe/S) cluster 
protein (see Chapter 3). In this section of the Introduction, I will cover the basics of Fe/S 
cluster proteins and their functions in relation to DNA replication, as these concepts are 
important for the understanding of sT’s role in promoting replication. 
 Fe/S clusters are ubiquitous and evolutionary ancient co-factors (113-115). They 
are usually incorporated into proteins through coordination of iron by cysteine or 
histidine residues (116). Other ligands, such as aspartic acid, arginine, and serine, can 
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also assist in the integration of more complex Fe/S clusters (116). Common cluster types 
include [2Fe-2S], [3Fe-4S], and [4Fe-4S]. The binuclear [2Fe-2S] cluster can be 
considered as a building block for other clusters. For example, the tetranuclear [4Fe-4S] 
cluster can be assembled from two binuclear clusters, and the trinuclear [3Fe-4S] cluster 
can be assembled from a tetranuclear cluster via the loss of one Fe to oxidation (113, 
117). Cluster conversions are typical during assembly but they also pose as a technical 
challenge during Fe/S cluster protein purification since the clusters are sensitive to 
oxidative degradation. Intracellular formation of these clusters involves well-orchestrated 
biosynthetic machineries located in the mitochondria (Fe/S cluster (ISC) assembly 
machinery systems) and cytosol (cytosolic Fe/S protein assembly (CIA) systems) (118-
120), both of which are still being characterized in the field. Of note, it remains to be 
investigated how the Fe/S clusters are loaded onto target proteins, how accessory proteins 
contribute to the maturation of Fe/S cluser proteins, and how the biogenesis pathways are 
regulated. 
1.4.2: Roles of iron-sulfur cluster proteins in DNA replication and repair 
 Due to their structural plasticity and versatile chemical/electronic features, Fe/S 
clusters can play a role in electron transfer, substrate binding/activation, Fe/S storage, 
regulation of gene expression, and enzyme activity. Other than their ideal role in 
mediating electron transport in the mitochondria, Fe/S clusters are important for a 
number of nucleic acid processing enzymes, including those involved in DNA 
unwinding, endonuclease activity, reduction of ribonucleoties to deoxyribonucleotides, 
and DNA polymerization (115, 119, 121-126).  
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DNA helicase enzymes, including xeroderma pigmentosum group D (XPD), 
Rad3, Fanconi anemia complementation group J (FancJ), ChlR1, regulator of telomere 
elongation helicase 1 (RTEL1) and DNA replication helicase/nuclease 2 (Dna2), all carry 
a conserved Fe/S cluster essential for helicase activities (126-128). The Fe/S cluster 
domain has been hypothesized to act as a molecular ‘‘plowshare’’ in unwinding DNA 
duplex as ssDNA is drawn through (123-125, 127, 129, 130). XPD is important in NER 
and FancJ mediates the unwinding of DNA for repair (126). Mutations in the Fe/S 
clusters of XPD and FancJ lead to the loss of helicase activities and could manifest 
clinically as trichothiodystrophy and Fanconi anemia, respectively (131, 132). 
Mutagensis studies on yeast XPD (Rad3) have shown that cysteine mutations lead to 
dysregulated excision repair of UV photoproducts (128). The ability for Rad3 to induce 
the coupling of ATP hydrolysis with DNA translocation is attributed to the presence of 
the Fe/S cluster (123). ChlR1 is a FancJ-like helicase important for sister chromatid 
cohesion and RTEL1 is involved in telomere maintenance, both enzymes require intact 
Fe/S clusters to function (126). Dna2 is implicated in DSB repair and mutations in the 
Fe/S region of the protein lead to the failure to bind broken DNA (126). 
The majority of cellular DNA synthesis is performed by three DNA polymerases, 
namely Pol α, Pol δ, and Pol ε (133). Pol α cooperates with DNA primases to synthesize 
short RNA primers, which are then used by Pol δ and Pol ε to synthesize the lagging and 
leading strands, respectively (134, 135). Eukaryotic primases also contain a conserved 
Fe/S domain required for the initiation of DNA replication (136-138). All these DNA 
polymerases and primases require Fe/S clusters for the fomation of active, stable 
replisome complexes (122).  
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Ribonucleotide reductases (RNRs) are enzymes that reduce ribonucleotides to 
deoxyribonucleotides (dNTPs) for DNA synthesis (139). Dsyregulated RNRs could 
increase misincorporation of dNTPs, subsequently leading to the accumulation of DNA 
damage and apoptosis (139, 140). Eukaryotic RNRs require an iron center to sustain a 
diferric tyrosyl radical for the reduction reaction. Three classes of RNRs have been 
described to date, and in particular, class III RNRs requires a Fe/S cluster to generate the 
radical (141). 
A handful of Fe/S cluster proteins has now been identified, but their discovery has 
been lagging behind the studies of other metal cofactor. As mentioned above, Fe/S cluster 
proteins are sensitive to oxygen and the intact clusters are often degraded during 
purification. However, technical advancement has been advantageous in identifying 
novel Fe/S cluster proteins. The development of electron paramagnetic resonance (EPR), 
a technique to study molecules or atoms with an unpaired electron, helps show that Fe/S 
cluster proteins have paramagnetic properties (142). With Mössbauer spectroscopy, 
which is a sensitive method to detect minute changes in the energy levels of an atomic 
nucleus in response to its environment, cluster conversions can now be studied (143). 
These two techniques can definitely detect the presence of and identify the types of Fe/S 
clusters in the protein of interest. Nonetheless, since they require a large amount of 
purified proteins for analysis, they are difficult to employ with proteins expressed in 
mammalian cells. A technique to detect Fe/S clusters present in mammalian proteins has 
yet to be developed. 
1.4.3: Viral iron-sulfur cluster proteins 
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 Fe/S cluster proteins are common in mammalian cells, bacteria, and yeast. 
However, whether viruses have Fe/S cluster proteins remains an unanswered question. In 
fact, there is only one report on rotavirus non-structural protein NSP5 being a viral Fe/S 
protein with a binuclear cluster coordinated by two conserved cysteines (144). It has been 
shown that the Fe/S cluster modulates the affinity of NSP5 for single-stranded RNA, and 
it is hypothesized that perhaps the cluster is important for packaging and/or replication of 
the viral genome (144).  
 There are seven well-conserved cysteines found in the C-terminal half of MCPyV 
sT. Early reports have shown that the cysteines are important for the coordination of two 
zinc ions in SV40 sT (145, 146). However, these in vitro studies also suggested that ions 
other than zinc could be incoporated into the protein (146). Therefore, it remains of 
interest to investigate whether MCPyV sT is also a metalloprotein, and if so, how the 
metal cofactor contributes to the functionality of sT.  
 
1.5: Scope of My Work 
 My work focused on the two major MCPyV early proteins, LT and sT, and their 
relation to MCPyV replication. In Chapter 2, I explore the role of the host DDR in 
MCPyV LT-mediated replication. I provide evidence to show that the DDR factors and 
LT colocalize at the sites of actively replicating viral factories in the cell, and that the 
integrity of the ATM and ATR pathways is required for optimal viral replication. In 
Chapter 3, I identify sT as a novel Fe/S cluster protein and show that sT Fe/S clusters 
may play a direct role in LT-mediated viral DNA replication. I also present evidence to 
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support that sT can be targeted by a potent antiviral drug to dampen viral replication. 
Finally, in Chapter 4, as a continuation of the previous chapter, I provide data to support 
the notion that sT expressed in mammalian cells might also contain Fe/S clusters. I also 
offer additional discussion on how sT could be directly contributing to MCPyV 
replication without stabilizing LT. 
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CHAPTER 2: HOST DNA DAMAGE RESPONSE FACTORS LOCALIZE TO 
MERKEL CELL POLYOMAVIRUS DNA REPLICATION SITES TO SUPPORT 
EFFICIENT VIRAL DNA REPLICATION 
 I was the principal investigator who designed and performed the experiments in 
this chapter, and prepared the associated manuscript published in the Journal of Virology. 
Dr. Xin Wang was of great assistance in performing some of the Southern blotting 
experiments while teaching me the techniques. Dr. Jing Li helped with the Merkel cell 
polyomavirus infection experiment. Dr. Christopher B. Buck provided the MCPyV 
virions/pseudovirions, and contributed to the discussion of the project and the critique of 
the manuscript. 
 
 
 
 
 
 
 
 
 
This research was originally published in the Journal of Virology. Sabrina H. Tsang, 
Xin Wang, Jing Li, Christopher B. Buck, and Jianxin You. Host DNA Damage Response 
Factors Localize to Merkel Cell Polyomavirus DNA Replication Sites to Support 
Efficient Viral DNA Replication. J Virol. 2014 Mar;88(6):3285-3297. 
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2.1: Chapter Summary 
Accumulating evidence indicates a role for MCPyV in the development of MCC, 
making MCPyV the first polyomavirus to be clearly associated with human cancer. With 
the high prevalence of MCPyV infection and the increasing amount of MCC diagnosis, 
there is a need to better understand the biology of the virus and its oncogenic potential. In 
this chapter, I examined the relationship between the host DDR and MCPyV replication. 
I found that components of the ATM- and ATR-mediated DDR pathways accumulate in 
MCPyV LT-positive nuclear foci in cells infected with native MCPyV virions. To further 
study MCPyV replication, I employed our lab’s established system, in which 
recombinant MCPyV episomal DNA is autonomously replicated in cultured cells. Similar 
to native MCPyV infection, where both MCPyV origin and LT are present, the host DDR 
machinery colocalized with LT in distinct nuclear foci. Immunofluorescence in situ 
hybridization and bromodeoxyuridine (BrdU) incorporation analysis showed that these 
DDR proteins and MCPyV LT in fact colocalized at the actively replicating MCPyV 
replication complexes, which were absent when a replication-defective LT mutant or an 
MCPyV-Ori mutant was introduced in place of wild-type LT or wild-type viral Ori. 
Inhibition of DDR kinases using chemical inhibitors and ATR/ATM small interfering 
RNA (siRNA) knockdown reduced MCPyV DNA replication, without significantly 
affecting LT expression or the host cell cycle. This study demonstrates that these host 
DDR factors are important for MCPyV DNA replication, providing new insight into the 
host machinery involved in the MCPyV life cycle. 
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2.2: Introduction 
MCPyV was discovered in 2008 in MCC, a highly aggressive form of skin cancer 
with neuroendocrine characteristics (6). Independent studies have subsequently found 
MCPyV to be clonally integrated in more than 80% of all MCC cases (6). 
Epidemiological surveys for MCPyV seropositivity (55) and sequencing analyses of 
healthy human skin (147) have shown that MCPyV is an abundant virus frequently shed 
from healthy human skin surfaces, suggesting that MCPyV may represent a common 
component of the human skin microbial flora. Immunosuppression, advanced age, and 
excessive exposure to UV radiation have been identified as the principle risk factors for 
MCC (2). Although MCC is uncommon, its incidence has tripled over the past 20 years, 
and the concern for MCC grows as the size of the aging population with prolonged sun 
exposure increases (4). To date, much of our knowledge of polyomaviruses is inferred 
from decades of research on SV40, which is phylogenetically distant from MCPyV and is 
not known to cause cancer in humans (6, 8). It is likely that much remains to be learned 
about the applicability of well-understood aspects of SV40 biology to the MCPyV life 
cycle and the oncogenic potential of MCPyV in humans. 
Like other polyomaviruses, MCPyV is a small, non-enveloped virus with a 
circular, dsDNA genome of ∼5 kb (31). An NCRR divides the genome into early and late 
coding regions. The NCRR contains the viral Ori and regulatory elements/promoters for 
viral gene transcription (18, 29). The early region encodes four proteins, namely, LT, sT, 
57kT, and ALTO (10, 31). The late region encodes a major capsid protein, VP1, and a 
minor capsid protein, VP2 (56, 148). 
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Similar to SV40 LT, MCPyV LT is a multifunctional protein that plays an 
important role in viral replication and host cell cycle manipulation (39, 104, 149). It 
contains a number of domains that are conserved among polyomaviruses, including an 
Rb-binding domain, DnaJ domain, and CR1 domain (27). LT also has an OBD and a C-
terminal helicase domain, both of which are required for initiating viral replication (17, 
18, 29). 
With little being known about the MCPyV life cycle, I am interested in studying 
how the interactions between viral proteins and the host machinery contribute to viral 
replication and/or MCC oncogenesis. Emerging evidence has suggested that the host 
DDR is targeted by a wide variety of DNA and RNA viruses. The host DDR is composed 
of a network of proteins that recognize and repair various types of DNA damage. The 
major players in this signaling cascade are two PIKKs, namely, ATM and ATR kinases. 
While ATM is primarily activated upon DSBs, ATR is responsive to SSBs (60). 
Normally, DSBs are recognized by the heterotrimeric MRN complex (60), which in turn 
induces autophosphorylation and activation of ATM (69). Activated ATM 
phosphorylates the histone variant H2AX, as well as the downstream kinase Chk2, which 
signals through a number of effectors, leading to cell cycle arrest (60). Depending on the 
severity of the damage, this pathway can also promote senescence or apoptosis. In 
parallel, SSBs and single-stranded DNA accumulation at stalled replication forks are 
recognized and coated by RPA (67). After ATR is recruited and activated by RPA, it 
phosphorylates H2AX and the downstream kinase Chk1, which shares a number of 
downstream targets with Chk2. Previous research has shown that there is a significant 
amount of cross talk between the ATR and ATM pathways (60, 72-75). 
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Multiple groups have shown that polyomavirus infection or ectopic expression of 
polyomavirus LT proteins is capable of inducing a DDR in the host cell (39, 105-111). 
The mechanism by which these LT proteins activate the host DDR is less well 
understood, but it has been suggested that polyomaviruses utilize the DDR machinery for 
viral replication. For example, both mouse polyomavirus (MPyV) infection and SV40 
infection have been shown to induce a DDR that is crucial for viral replication (106, 
110). More specifically, ATM-mediated phosphorylation of SV40 LT is important for its 
ability to drive replication of the viral origin (110, 112). Recent reports of human 
polyomaviruses JCPyV (109) and BKPyV (108) have also shown that ATR and ATM are 
both activated upon infection and that they play an important role in viral genome 
amplification and virion production. 
In an earlier study, our lab has provided a mechanistic analysis of MCPyV DNA 
replication in cultured cells (104). Additional study from our lab has shown that ectopic 
expression of MCPyV LT activates host DDR, leading to the inhibition of cellular 
proliferation (39). It remains unknown whether MCPyV also utilizes the host DDR 
machinery for optimal viral replication and/or virion production. In my study, I 
investigated the role of host DDR in MCPyV replication. Using U2OS cells infected with 
MCPyV as well as a MCPyV DNA replication system that we previously established 
(104), I show that MCPyV LT and components of the ATR- and ATM-mediated DDR 
pathways colocalize at actively replicating MCPyV foci in the nucleus. By combining 
immunofluorescent staining, immunofluorescence in situ hybridization (immuno-FISH), 
BrdU incorporation, and Southern blotting analyses, I demonstrate that DDR proteins are 
important for maintaining robust MCPyV DNA replication. 
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2.3: Results 
2.3.1: Colocalization of host DDR proteins and MCPyV LT in nuclear foci in cells 
infected with native MCPyV virions 
I first investigated the relationship between the host DDR and MCPyV replication 
in cells infected with native MCPyV virions. With the help of Dr. Jing Li from our lab, I 
began infection studies using cells of the U2OS cell line, which, in contrast to many other 
cell lines, have intact ATR and ATM pathways. Our lab has previously observed an 
activated DDR in U2OS cells upon ectopic MCPyV LT expression (39). Native MCPyV 
infection efficiency was about 10 to 15% in U2OS cells, as indicated by positive 
immunostaining of MCPyV LT at day 5 post-infection (dpi). It has been shown that 
MCPyV transcription and replication are highly restricted in all cell lines so far tested 
(11, 54, 148). Consistent with these observations, I observed a very low level of MCPyV 
LT expression in U2OS cells infected with native MCPyV virions. As our lab published 
previously (39), LT typically showed a diffuse staining pattern in the nucleus, but in ∼1% 
of MCPyV-infected cells, I was able to observe punctate LT foci in the nucleus (Fig. 
2.1A). Interestingly, these foci showed clear colocalization with the phosphorylated 
H2AX (referred to as γH2AX), a classic marker of DNA damage (Fig. 2.1A). I also 
observed colocalization of LT with ATR and pChk2T68, with the latter being an indicator 
for the activation of an ATM-mediated DDR (Fig. 2.1A). This result suggests that the 
components of the ATR and ATM pathways are recruited to the MCPyV LT nuclear foci. 
In contrast, cells infected with MCPyV pseudovirus carrying a green fluorescent protein 
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(GFP) reporter construct instead of the MCPyV genome did not show such DDR foci 
(data not shown). 
To rule out the possibility that the MCPyV capsid proteins are causing this 
phenomenon, Dr. Christopher B. Buck pseudotyped MCPyV genomic DNA into the L1-
L2 capsid of HPV16. The pseudovirions were then used to transduce U2OS cells. 
Although the LT-positive cells were equally rare, I was again able to find cells that 
displayed LT/pChk2T68 colocalization in the nuclear foci (Fig. 2.1B). In contrast, MCPyV 
LT and pChk2T68 signals were not detected in the untransduced neighboring cells (Fig. 
2.1B). These data suggest that the MCPyV genome, and not the incoming MCPyV virion 
proteins, is responsible for the DDR protein/LT colocalization phenotype that I observed 
in MCPyV-infected U2OS cells. 
2.3.2: The MCPyV genome alone is able to induce DDR factor/LT colocalization in 
nuclear foci 
Based on what we saw in the HPV/MCPyV pseudovirus-transduced cells, we 
believed that the MCPyV genome alone could also lead to DDR factor/LT colocalization 
in nuclear foci. I next transfected the religated MCPyV genome into U2OS cells. The 
transfected cells could be identified by positive LT staining (Fig. 2.2). In ∼5% of 
transfected cells, I was able to see LT colocalizing with γH2AX, ATR, and pChk2T68 in 
nuclear foci at day 4 post-transfection (Fig. 2.2). These data confirm the colocalization of 
host DDR components with LT expressed from the native MCPyV genome. It is 
important to note that, although we have previously shown that LT expression can 
activate the overall activity of host DDR (39), the data presented in Fig. 2.1 and 2.2 
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reveal the specific accumulation of the host DDR components at the LT foci in cells 
treated with MCPyV virions/pseudovirions/religated genomes. 
2.3.3: Host DDR machinery colocalizes with MCPyV LT at nuclear foci in the presence 
of the viral Ori 
Although I was able to detect DDR factor/MCPyV LT colocalization using native 
virion infection and religated genome transfection, the rarity of cells expressing 
detectable amounts of LT in these systems makes them relatively intractable. In addition, 
with native MCPyV systems, I was not able to prove whether the DDR factors had a 
specific effect on MCPyV DNA replication. In our previous studies, our lab established a 
system to detect MCPyV replication complexes in C33A cells (104). Notably, the LT foci 
found in MCPyV-infected and MCPyV genome-transfected cells described above greatly 
resembled the MCPyV LT replication complexes observed in cells co-transfected with 
MCPyV LT and the viral Ori described in our previous study (104). I therefore adopted 
this LT/Ori co-transfection system in C33A cells to see if the host DDR machinery is 
involved in MCPyV DNA replication. 
I co-transfected C33A cells with a plasmid carrying MCPyV LT and a plasmid 
carrying the MCPyV Ori and then detected the signals of various DDR proteins. As a 
negative control, I examined the behavior of a plasmid carrying a mutant MCPyV Ori 
(Ori350) that has previously been shown to bind MCPyV LT but is incompetent for LT-
mediated replication (18). A construct with the Ori of SV40, which cannot be replicated 
by MCPyV LT, served as an additional negative control. MCPyV LT and most of the 
host DDR proteins had a diffuse nuclear pattern in the cells co-transfected with the 
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plasmid carrying the replication-defective Ori350 or the SV40 Ori (Fig. 2.3 and 2.4 and 
data not shown). However, when the wild-type MCPyV Ori was present, LT formed 
distinct foci in the nucleus in ∼20% of LT-positive cells (Fig. 2.3 and 2.4). This is 
consistent with our previous data showing that MCPyV LT formed replication foci in the 
nucleus in the presence of the viral Ori (104). Interestingly, multiple components of the 
ATM-mediated DDR were also localized at these LT foci (Fig. 2.3). Approximately 50 
cells displaying LT foci were quantified from each of the three independent experiments. 
γH2AX, Nbs1, pATMS1981, and pChk2T68 were localized at LT foci in 85.5% ± 4.0%, 
87.7% ± 3.3%, 54.2% ± 13.6%, and 91.5% ± 4.4% of cells displaying LT foci, 
respectively. 
I next investigated the other arm of the host DDR, the ATR-mediated pathway. 
Similar to what I observed with components of the ATM-mediated DDR, components of 
the ATR-mediated pathway also colocalized with LT in nuclear foci (Fig. 2.4). ATR and 
pChk1S317 were observed to colocalize with LT nuclear foci in 95.8% ± 0.4% and 80.2% 
± 7.8% of cells displaying LT foci, respectively. In response to DNA damage, RPA32, 
the 32-kDa subunit of RPA, is also hyperphosphorylated by ATM, ATR, and DNA-PK to 
contribute to repair DNA synthesis (150). I also detected the signal of RPA32S33 
phosphorylation at the LT nuclear foci in 100% of cells displaying LT foci (Fig. 2.4). 
Because the factors from both ATM- and ATR-mediated DDR pathways did not 
accumulate in distinct foci in cells co-transfected with an MCPyV LT-encoding construct 
and a control vector carrying the SV40 Ori (data not shown), these data suggest that the 
DDR factors are associated with MCPyV LT at nuclear foci in an MCPyV Ori-dependent 
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manner. C33A cells co-transfected with wild-type LT and Ori350 also displayed a diffuse 
pattern for both LT and various DDR factors (Fig. 2.3 and 2.4), further supporting the 
suggestion that the formation of DDR protein/LT foci depends on the LT-mediated 
replication of MCPyV DNA. 
Dr. Jing Li and I also performed western blot analysis to examine the activation 
status of the ATM- and ATR-mediated DDR pathways in C33A cells transfected with 
MCPyV LT together with or without MCPyV Ori (Fig. 2.5). Consistent with our previous 
observations in U2OS cells (39), activation of the ATR pathway (as indicated by the 
induction of Chk1S345 phosphorylation) was observed in C33A cells expressing MCPyV 
LT, either in the presence or in the absence of MCPyV Ori (Fig. 2.5A). MCPyV LT 
expression also appeared to moderately induce ATMS1981 phosphorylation in C33A cells, 
indicating the activation of ATM kinase in these cells (Fig. 2.5A). In addition, C33A cells 
transfected with MCPyV LT either with or without MCPyV Ori also showed increased 
RPA32S33 phosphorylation and an increased γH2AX signal (Fig. 2.5). These results 
demonstrate that the ATM- and ATR-mediated DDR pathways are activated in C33A 
cells expressing MCPyV LT. 
2.3.4: Host DDR machinery and MCPyV LT colocalize at actively replicating viral 
origins in the nucleus 
Previously, we have detected DNA damage in U2OS cells upon ectopic 
expression of full-length MCPyV LT or C-terminus-only LT truncation mutants (39). It is 
possible that the DDR machinery is recruited to the sites of DNA breaks on the host 
genome. To ensure that the DDR factor/LT nuclear foci that I observed in C33A cells are, 
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in fact, at the MCPyV Ori and not sites of repair on the host genome, Dr. Xin Wang and I 
performed immuno-FISH to detect the localization of MCPyV Ori with respect to the 
host DDR machinery. C33A cells were co-transfected with a plasmid carrying MCPyV 
LT and a different plasmid carrying the MCPyV Ori. I then detected the localization of 
LT and DDR proteins by immunofluorescent staining and used a specific probe to detect 
the MCPyV Ori-containing plasmid by FISH (Fig. 2.6A). The FISH signal was detected 
only with the MCPyV Ori-specific probe and not with a negative-control probe 
recognizing the HPV16 genome, which is absent from the HPV-negative C33A cells 
(Fig. 2.6A). Consistent with our previous observation (104), MCPyV LT and MCPyV Ori 
colocalized in nuclear foci (Fig. 2.6A, top), which we believe to be MCPyV replication 
factories containing actively amplifying viral DNA and not single copies of the origin 
(see below). In addition, the various components of the host DDR machinery, such as 
ATR, pChk2T68, and γH2AX, also colocalized with the MCPyV Ori foci (Fig. 2.6A and 
data not shown). These data demonstrate the recruitment of DDR proteins to the MCPyV 
Ori complex, confirming that the nuclear foci that I observed are not the result of LT-
induced DNA damage on the host chromosomes. My results also suggest that the DDR 
proteins may be involved in MCPyV DNA replication. 
To rule out the possibility of nuclear aggregation and to ensure that the nuclear 
foci that I observed in the presence of MCPyV Ori are, in fact, the sites of viral 
replication, I tested for BrdU incorporation at these foci. Previously, we have used this 
technique to demonstrate the incorporation of BrdU specifically in MCPyV LT/Ori foci 
(104). Consistently, in cells co-transfected with MCPyV LT and the Ori, the BrdU signal 
was observed in distinct nuclear foci, whereas in the control samples, the BrdU signal 
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was minimal (Fig. 2.6B). Interestingly, both ATR and pChk2T68 were found to colocalize 
with the BrdU signal (Fig. 2.6B), suggesting that the DDR factor/LT foci that I observed 
are indeed sites of active, robust viral DNA replication. Nevertheless, it is also possible 
that cells without these replication foci are maintaining low levels of MCPyV replication 
that are undetectable by immuno-FISH and BrdU incorporation analysis described here. 
2.3.5: Formation of DDR protein/MCPyV LT nuclear foci is viral replication dependent 
To confirm that the nuclear foci at which MCPyV LT and DDR factors colocalize 
are, in fact, dependent on viral DNA replication, I employed the U2OS 2-6-3 system, in 
which a LacO array has been integrated into the cellular genome of U2OS cells (151). 
U2OS 2-6-3 cells were transfected with a plasmid carrying LacR-fused MCPyV LT. 
Consequently, the LT expressed in these cells was tethered to the LacO array due to the 
tight binding of LacR to LacO, which was seen as a single LT-positive focus in each cell 
(Fig. 2.7A, LT). I immunostained LacR-LT-transfected U2OS 2-6-3 cells for various 
DDR proteins to see if LT itself physically interacts and brings these DDR factors to the 
LacO array. However, I observed no colocalization of LT and DDR proteins in these 
cells, suggesting that LT itself, even though concentrated in a single focus within the 
nucleus, cannot tether host DDR proteins to the LacO site. Considering the high affinity 
of LacR to LacO and the fact that the genome of U2OS 2-6-3 cells transfected with LacR 
alone cannot replicate normally (data not shown), we believe that the binding of LacR to 
LacO is so tight that this particular locus cannot be unwound/replicated. The absence of 
DDR factor/LT colocalization in this system suggests that the focus formation seen in 
Fig. 2.1 to 2.4 and 2.6 is replication dependent. 
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In addition, our lab had constructed a number of MCPyV LT mutants on the basis 
of homology to SV40 LT helicase mutations that abolish SV40 replication. When I co-
transfected C33A cells with wild-type LT and the wild-type viral Ori, I could robustly 
detect LT-mediated replication of the Ori plasmid by Southern blotting (Fig. 2.7B, Newly 
synthesized DNA). However, when MCPyV LT helicase mutants were transfected in 
place of the wild-type LT, replication of the Ori plasmid was completely abolished, 
confirming that these LT mutants were, in fact, replication defective. The mutants were 
expressed at levels comparable to those of wild-type LT (Fig. 2.7B, LT), indicating that 
the failure to replicate the wild-type Ori plasmid was not due to the gross instability of 
the mutants. DNA digested with only BamHI showed comparable hybridization of the 
Southern blot probe to the Ori-containing plasmid (Fig. 2.7B, Loading control), 
demonstrating comparable transfection efficiency and loading. The Southern blotting 
results correlated with a dramatic reduction in LT focus formation (quantified in Fig. 
2.7C). This provides additional evidence for the notion that the formation of LT foci 
depends on productive replication of viral DNA. 
Moreover, wild-type LT co-transfected with Ori350 showed a much more 
attenuated ability to replicate the plasmid carrying the mutated Ori (Fig. 2.7B), and this 
also correlated with the decrease in the number of LT foci quantified (Fig. 2.7C). These 
data from LT mutants and the Ori350 mutant support the notion that the DDR protein/LT 
foci observed in my system are, in fact, viral replication dependent. 
2.3.6: Treatment with DDR inhibitors reduces MCPyV DNA replication 
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Next, I tested the functional importance of the host DDR to MCPyV by studying 
the effects of DDR inhibitors on autonomous MCPyV DNA replication. Wortmannin was 
used in this study because it is a potent, covalent inhibitor of PI3Ks (152), which include 
ATM, ATR, and DNA-PK. However, it has been reported that wortmannin inhibits DSB 
repair and not SSB repair (153) and that, at a higher concentration (20 µM), it efficiently 
inhibits ATM activation in vivo (154). Therefore, I also tested the effects of NU6027, 
which specifically inhibits ATR activity but not ATM or DNA-PK activity (155), on 
MCPyV DNA replication. I first confirmed by western blot analysis that wortmannin can 
reduce etoposide-induced ATMS1981 phosphorylation and that NU6027 can inhibit UVC-
induced Chk1S345 phosphorylation (data not shown). Dr. Xin Wang and I then tested 
these drugs in C33A cells transfected with the pT+Ori plasmid carrying the sequences of 
MCPyV LT, sT, and the viral Ori, which has been shown to support autonomous 
replication in our previous study (104). In untreated and DMSO-treated C33A cells, 
robust pT+Ori replication was detected (Fig. 2.8). In contrast, in the DDR inhibitor-
treated samples, I noticed a decrease in pT+Ori replication (Fig. 2.8A and B). This 
reduction was particularly drastic in wortmannin-treated C33A cells (Fig. 2.8A and B), 
possibly due to wortmannin's multi-targeting of PI3Ks (see Chapter 2.4 Discussion). Both 
wortmannin and NU6027 treatments also efficiently inhibited the replication of the 
religated MCPyV genome (data not shown). Consistent with the Southern blotting 
results, I observed a decrease in replication focus formation in drug-treated cells by 
immunofluorescent staining (data not shown). We believe that the decrease in 
autonomous replication is a consequence of DDR inhibition, as drug treatment had a 
minimal effect on MCPyV LT expression (Fig. 2.8A). 
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I also performed flow cytometry analysis to test how wortmannin and NU6027 
affect the host cell cycle, which could in turn affect pT+Ori replication. Although 
wortmannin treatment had a minimal effect on the cell cycle profile, NU6027 treatment 
led to an increase in the G1 population compared to that for the pT+Ori-transfected, 
DMSO-treated control (Fig. 2.8C). Even though I detected a ∼70% decrease in pT+Ori 
replication upon NU6027 treatment (Fig. 2.8B), part of this reduction could be a 
consequence of G1 arrest in C33A cells. I further tested if drug treatment affects cellular 
proliferation by immunostaining drug-treated C33A cells for Ki-67, which is an 
established marker for cell proliferation detected in all active phases of the cell cycle (G1, 
S, and G2/M) but not in resting cells (G0). As shown in Fig. 2.8D, neither DDR inhibitor 
had much of an effect on Ki-67 positivity. This demonstrates that the drug-treated cells 
were actively proliferating. 
2.3.7: siRNA knockdown of ATR and/or ATM inhibits MCPyV DNA replication 
To rule out the possibility that wortmannin and NU6027 have off-target and/or 
cell cycle effects on C33A cells that could affect MCPyV DNA replication, Dr. Xin 
Wang and I performed siRNA knockdown of ATR and/or ATM to see if we could 
recapitulate observations with the DDR inhibitors. siRNA knockdown of ATR or ATM 
inhibited the activation of Chk1S345 and Chk2T68 phosphorylation, respectively, in cells 
treated with UVC (data not shown). We co-transfected pT+Ori with control siRNA, 
siRNA against ATR (siATR), and/or siRNA against ATM (siATM) into C33A cells and 
performed Southern blotting to detect newly synthesized pT+Ori. At 48 hpt, both ATR 
and ATM were effectively knocked down (Fig. 2.9A). Similar to what I have observed 
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with the DDR inhibitors, ATR and ATM knockdown reduced autonomous pT+Ori 
replication in C33A cells (Fig. 2.9A and B). This decrease was even more apparent when 
both ATR and ATM were knocked down (Fig. 2.9A and B). I was also able to observe a 
decrease in replication focus formation in ATR/ATM double-knockdown cells by 
immunofluorescent staining (data not shown). The fact that ATR/ATM double-
knockdown cells showed a slightly greater reduction in pT+Ori replication than ATR or 
ATM single-knockdown cells could be explained by the functional redundancy of these 
two kinases. The decrease in pT+Ori replication is attributed to the knockdown of ATR 
and ATM, as siRNA treatment had a minimal effect on MCPyV LT expression (Fig. 
2.9A), host cell cycle (Fig. 2.9C), and cellular proliferation (Fig. 2.9D) in C33A cells. 
These data suggest that both ATR- and ATM-mediated DDR is important for optimal 
MCPyV DNA replication. 
 
2.4: Discussion  
Since its discovery, MCPyV has provided a new model for studying the 
oncogenic potential of polyomaviruses in humans. Although there is evidence suggesting 
that the interactions between LT and host cell cycle-regulatory proteins contribute to 
tumor development (27, 39), the exact oncogenic mechanism of MCPyV has not yet been 
established. Currently, we have limited understanding of the MCPyV life cycle, including 
viral entry, replication, and propagation processes. Recent reports on MCPyV receptor 
usage (54, 56, 59) and tropism (148) have begun to shed light on MCPyV basic biology. 
Our study of the host factors required for MCPyV replication has also started to tease out 
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the mechanistic details of viral genome amplification (104). Using our established system 
for the study of MCPyV DNA replication (104), I investigated additional host machinery 
that is important for this process. 
In this study, I showed that, in cells infected with MCPyV, components of the 
ATM and ATR kinase pathways accumulate in MCPyV LT-positive nuclear foci. 
Colocalization of these DDR factors and MCPyV LT in nuclear foci was also observed in 
cells either transduced with pseudotyped virions composed of the HPV capsid and 
MCPyV genome or transfected with the MCPyV genome. This suggests that gene 
expression from the MCPyV genome and not incoming virion-associated proteins is 
responsible for inducing the formation of DDR factor/LT nuclear foci. Using our 
previously established immuno-FISH method to visualize MCPyV LT/Ori replication 
complexes in cells (104), I showed that the DDR proteins and MCPyV LT colocalize at 
complexes that contain actively replicating MCPyV DNA. We believe that focus 
formation represents the presence of robust viral DNA replication, where the newly 
synthesized DNA has accumulated to a level detectable by immuno-FISH/BrdU staining. 
It is possible that cells without these replication factories are maintaining low levels of 
MCPyV replication. While the immunofluorescent staining revealed the formation of 
MCPyV DNA replication factories in the presence of robust replication, Southern blot 
analysis was used to demonstrate the overall level of MCPyV replication maintained in 
cells with and without replication factories. Abrogation of the host DDR, using either 
chemical inhibitors (wortmannin and NU6027) or ATR/ATM siRNA knockdown, led to 
a decrease in MCPyV DNA replication, supporting the conclusion that these components 
of the host DDR are essential for robust viral genome amplification. 
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To date, it has been technically challenging to study the MCPyV life cycle in 
cultured cell lines due to the lack of a known natural host cell and the inefficient 
replication of the native viral genome in culture (reviewed in references (156) and (157)). 
In my initial experiments, I was able to detect accumulation of DDR factors in the 
MCPyV LT-positive nuclear foci in a limited number of cells infected with native 
MCPyV virions. To further investigate the involvement of host DDR in MCPyV 
replication, my study relied on a MCPyV DNA replication system that our lab previously 
established (104), in which MCPyV LT and Ori plasmids were transiently transfected 
into C33A cells. Although this system suggests that the DDR machinery is important for 
MCPyV replication, it is essential to investigate how DDR activation contributes to viral 
replication in more natural MCPyV replication systems once they are established. 
Currently, there is some uncertainty about the nature of the precursor cells that give rise 
to MCC tumors (158). Understanding the behavior of MCPyV in MCC precursor cell 
types will be important for further elucidation of the oncogenic effects of the virus. 
In my study, I used the PI3K inhibitor wortmannin and ATR inhibitor NU6027 to 
show that the DDR response contributes to MCPyV replication. Since wortmannin not 
only inhibits ATM and ATR but also inhibits other members of the PIKK family, such as 
DNA-PK, I also tested a number of other DDR inhibitors, including NU7441 (a DNA-PK 
inhibitor), KU55933 (an ATM inhibitor), and AZD7762 (a Chk1 inhibitor). However, 
none of these drug treatments showed as dramatic of an effect as wortmannin and 
NU6027 (data not shown). This suggests that ATR may be more important for MCPyV 
replication than other DDR mediators. In line with the findings from the experiments 
performed with drug inhibitors (Fig. 2.8 and data not shown), assays with siRNA showed 
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a more dramatic reduction in LT-mediated replication when ATR was knocked down 
than when ATM was knocked down, while ATR and ATM double knockdown decreased 
replication to the level similar to that obtained with ATR single knockdown (Fig. 2.9A 
and B). 
Many groups have previously reported the activation of ATR- and/or ATM-
dependent DDR pathways upon viral infection or viral protein expression. HPV, 
adenovirus, herpes simplex virus, Epstein-Barr virus, and retroviruses all induce a DDR 
(76, 78). So far, research on polyomaviruses has also shown similar phenomena. 
However, despite the large amount of information on the activation of host DDR by 
many viruses, little is known about the mechanism by which these viruses trigger such a 
response in the host. Previously, SV40 LT alone has been shown to induce both ATR- 
and ATM-mediated DDR, and this DDR activation is dependent on LT's interaction with 
the mitotic spindle checkpoint kinase Bub1 (107). In addition, for JCPyV, there is 
evidence suggesting that its LT-mediated G2 cell cycle arrest is dependent on LT's ability 
to associate with cellular DNA (109). This observation leads to the speculation that 
perhaps the viral origin-binding domain and the non-specific DNA-binding domains on 
LT could tether this viral helicase to host chromosomes, allowing it to unwind host DNA, 
which in turn would trigger DDR complex recruitment to the cellular DNA. This idea is 
in line with a recent report on BKPyV that showed severe chromosomal damage upon 
BKPyV infection in the absence of ATR/ATM (108). Moreover, studies have shown that 
SV40 and BKPyV infection leads to the accumulation of a cell population with >4N 
DNA content (108). For MCPyV, it is possible that the DNA intermediates generated 
	   40	  
during viral DNA replication are recognized by the host cells as damaged DNA, which 
could trigger the DDR activation that we observed upon viral infection/replication. 
One of the most interesting questions remains: how exactly do viruses benefit 
from the activation of DDR? As mentioned above, ATR- and ATM-mediated DDR can 
help repair chromosomal damage caused by polyomavirus infection (108). This repair 
mechanism not only allows the host to sustain virus-induced DNA damage but also 
permits the virus to propagate without killing the host. For SV40 and JCPyV, there is 
evidence suggesting that the activation of ATM- and ATR-mediated checkpoint signaling 
leads to cell cycle arrest in S and G2 phases, which are conducive to viral replication 
(106, 109). We have also observed that MCPyV LT-induced ATR activation can lead to a 
modest G2 arrest (39), suggesting that the response may contribute to viral DNA 
replication by inducing a cellular environment that is beneficial for viral DNA 
replication. This model is consistent with a recent report from Cheng and colleagues 
showing that full-length LT can trigger growth inhibition in cultured cells (34). On the 
other hand, my immunofluorescent staining showed little ATR/ATM accumulation 
outside viral replication factories, so the virus-induced host DNA damage and repair are 
likely minimal. Furthermore, because the components of the ATM and ATR pathways 
localize to the sites of MCPyV replication, which contain replication factors and actively 
replicating viral DNA ((104); this study), the DDR proteins are likely playing a more 
direct role in MCPyV DNA replication. For example, the host DDR factors may promote 
viral DNA replication by repairing the viral replication-induced damage on its own DNA 
(110). 
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How these DDR proteins contribute to MCPyV DNA replication will be the focus 
of our lab’s future study. Activation and recruitment of DDR factors have also been 
observed during HPV replication (85, 86, 88, 159). For HPV, it is thought that the host 
machinery used for homologous recombination may be required for the circularization of 
the viral genome for virion packaging (88). Interestingly, our lab has demonstrated that 
the cellular protein BRD4 is recruited to both HPV and MCPyV replication complexes to 
contribute to viral DNA replication (104, 160). BRD4 has been shown to interact with the 
DDR protein ATAD5 (161, 162), suggesting that it may play a role in DNA damage 
repair-associated viral DNA replication. Future studies will investigate whether BRD4 is 
involved in recruiting DDR factors and DNA damage-specific polymerases to the 
MCPyV origin to support DDR-mediated viral replication. 
Most of the studies on polyomavirus replication have been performed using 
Southern blotting, quantitative PCR, or in vitro assays. The study presented in this 
chapter combined immunofluorescent staining, immuno-FISH, and BrdU incorporation to 
visualize the MCPyV replication complexes in cells. Building upon this platform, my 
study demonstrates that the host's DDR proteins are important for robust MCPyV DNA 
replication. This system will be useful for further investigation of the mechanistic role of 
DDR factors in MCPyV replication. For example, excessive UV exposure is a major risk 
factor for MCC. Future study will investigate whether over-stimulation of host DDR by 
sunlight exposure may cause abnormal viral DNA replication, leading to viral DNA 
integration and oncogenic progression. Collectively, not only do these studies on the 
relationship between the host DDR and MCPyV provide insight into the host machinery 
required for MCPyV genome amplification, but also they may shed light on virus-
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associated oncogenesis. Therefore, research on the components of the host DDR may 
have important clinical implications for MCPyV-associated MCC. 
 
2.5: Figures 
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Figure 2.1 
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Figure 2.1   MCPyV LT colocalizes with γH2AX, ATR, and pChk2T68 in MCPyV-
infected cells. U2OS cells were infected with native MCPyV virions (A) or MCPyV 
pseudovirus with HPV capsid carrying the MCPyV genome (B). Infected and uninfected 
control cells were fixed 5 days post-infection and stained for MCPyV LT (green) and 
DDR proteins (red) as indicated. The cells were counterstained with DAPI. 
Representative pictures from at least three experiments are shown. Bar, 5 µm. 
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Figure 2.2 
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Figure 2.2   MCPyV genome alone is sufficient to reproduce LT/DDR colocalization 
phenotype. U2OS cells were transfected with re-ligated MCPyV genome. Non-
transfected control (NTC) cells and transfected cells were harvested 4 days post-
transfection and stained for MCPyV LT (green) and DDR proteins (red) as indicated. The 
cells were counterstained with DAPI. Representative pictures from at least three 
experiments are shown. Bar, 5 µm. 
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Figure 2.3 
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Figure 2.3   ATM-mediated DDR machinery colocalizes with MCPyV LT in nuclear 
foci. C33A cells were co-transfected with a plasmid encoding MCPyV LT and with either 
a plasmid carrying the wild-type MCPyV origin (Ori) or the replication-defective origin 
(Ori350). At 48 hpt, cells were stained for MCPyV LT (green) and DDR proteins (red) as 
indicated. The cells were counterstained with DAPI. Representative pictures from at least 
three experiments are shown. Bar, 5 µm. 
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Figure 2.4 
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Figure 2.4   ATR-mediated DDR machinery colocalizes with MCPyV LT in nuclear 
foci. C33A cells were transfected as described in Fig. 2.3. At 48 hpt, cells were stained 
for MCPyV LT (green) and DDR proteins (red) as indicated. The cells were 
counterstained with DAPI. Representative pictures from at least three experiments are 
shown. Bar, 5 µm. 
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Figure 2.5 
 
 
 
Figure 2.5   MCPyV LT activates a host DDR in C33A cells. C33A cells were co-
transfected with either a plasmid encoding MCPyV LT or the control vector (Vec 1) and 
with either a plasmid carrying the MCPyV origin (Ori) or an empty vector (Vec 2). At 48 
hpt, nuclear proteins were harvested for western blotting with the indicated antibodies for 
ATM/ATR activation markers (A) or for γH2AX (B). PCNA was used as a loading 
control for nuclear proteins. 
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Figure 2.6 
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Figure 2.6   DDR proteins localize at replicating MCPyV origin in the nucleus. (A) 
C33A cells were co-transfected with a plasmid encoding MCPyV LT and a plasmid 
carrying the MCPyV origin (Ori). At 60 hpt, cells were stained for MCPyV LT and DDR 
proteins (red) as indicated. A specific probe recognizing the MCPyV Ori plasmid and a 
non-specific probe recognizing the HPV genome were used for FISH (green). The cells 
were counterstained with DAPI. Representative pictures from at least three experiments 
are shown. Bar, 5 µm. (B) C33A cells were co-transfected with a plasmid encoding 
MCPyV LT and with either a plasmid carrying the MCPyV origin (Ori) or an empty 
vector (Vec). At 44 hpt, cells were pulsed with BrdU for 2 hours. The cells were 
incubated in regular media for another 2 hours before they were fixed and stained for 
BrdU (green) and DDR proteins (red) as indicated. The cells were counterstained with 
DAPI. Representative pictures from at least three experiments are shown. Bar, 5 µm. 
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Figure 2.7 
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Figure 2.7   Formation of LT/DDR protein nuclear foci is dependent on MCPyV 
DNA replication. (A) U2OS 2-6-3 cells were transfected with a plasmid encoding LacR-
fused MCPyV LT. At 36 hpt, cells were stained for MCPyV LT (green) and DDR 
proteins (red) as indicated. The cells were counterstained with DAPI. Representative 
pictures from at least three experiments are shown. Bar, 5 µm. (B) C33A cells were co-
transfected with a plasmid encoding wild-type or mutant MCPyV LT (LT) and with 
either a plasmid carrying the wild-type MCPyV origin (Ori) or the replication-defective 
origin (Ori350). At 48 hpt, total cellular DNA was extracted for Southern blotting. 15 µg 
of DNA was digested with BamHI and DpnI to detect replicated origin plasmid, while 2 
µg of DNA was digested with only BamHI to show equal loading. Total protein 
extractions were used in western blotting to detect MCPyV LT and GAPDH. (C) C33A 
cells were transfected as described for panel B. At 48 hpt, cells were stained for MCPyV 
LT as in Fig. 2.3. About 150 LT-positive cells were quantified for the presence of LT 
nuclear foci. Data represent mean and standard deviation calculated from three 
independent experiments. 
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Figure 2.8 
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Figure 2.8   Treatment with wortmannin or NU6027 reduces MCPyV DNA 
replication. C33A cells were transfected with pT+Ori carrying MCPyV LT, sT, and the 
viral origin. At 20 hpt, cells were treated with DMSO, 20 µM wortmannin, or 20 µM 
NU6027. DMSO and the DDR inhibitors were refreshed every 16 hours. (A) At 52 hpt, 
total cellular DNA was extracted for Southern blotting. 30 µg of DNA was digested with 
XhoI and DpnI to detect replicated viral DNA, while 2 µg of DNA was digested with 
only XhoI to show equal loading. Quantification was normalized to non-treated control 
(NTC). Total protein extractions were used in western blotting to detect MCPyV LT and 
actin. (B) Quantification of replicated viral DNA bands. The value from NTC was 
arbitrarily set to 1. Data represent mean and standard deviation calculated from three 
independent experiments. ***, p<0.001. (C) C33A cells were transfected with pT+Ori or 
an empty vector (Vec). Cells were drug-treated as described for panel A. At 50 hpt, cells 
were pulsed with BrdU for 2 hours, then fixed and stained with BrdU antibody and 7-
AAD. About 12,000 GFP-positive cells were analyzed by flow cytometry. Representative 
gating strategy for each phase of the cell cycle is shown. Data represent mean and 
standard deviation calculated from three independent experiments. (D) C33A cells were 
transfected and drug-treated as described for panel A. At 52 hpt, cells were stained for 
Ki-67. About 200 cells were quantified for Ki-67 positivity. Data represent mean and 
standard deviation calculated from three independent experiments. 
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Figure 2.9 
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Figure 2.9   siRNA knockdown of ATR and ATM reduces MCPyV DNA replication. 
C33A cells were co-transfected with pT+Ori and either control siRNA (siControl), 
siATR, and/or siATM. (A) At 48 hpt, total cellular DNA was extracted for Southern 
blotting. 30 µg of DNA was digested with XhoI and DpnI to detect replicated viral DNA, 
while 2 µg of DNA was digested with only XhoI to show equal loading. Quantification 
was normalized to siControl. Total protein extractions were used in western blotting for 
ATR, ATM, MCPyV LT, and actin. (B) Quantification of replicated viral DNA bands. 
The value from control siRNA was arbitrarily set to 1. Data represent mean and standard 
deviation calculated from three independent experiments. ***, p<0.001. (C) C33A cells 
were co-transfected with the indicated siRNA and either pT+Ori or an empty vector 
(Vec). At 46 hpt, cells were pulsed with BrdU for 2 hours, then fixed and stained with 
BrdU antibody and 7-AAD. About 12,000 GFP-positive cells were analyzed by flow 
cytometry. Data represent mean and standard deviation calculated from three independent 
experiments. (D) C33A cells were transfected as described for panel A. At 48 hpt, cells 
were stained for Ki-67. About 200 cells were quantified for Ki-67 positivity. Data 
represent mean and standard deviation calculated from three independent experiments. 
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CHAPTER 3: MERKEL CELL POLYOMAVIRUS SMALL TUMOR ANTIGEN 
IS AN IRON-SULFUR CLUSTER PROTEIN THAT SENSITIZES VIRAL 
REPLICATION TO CIDOFOVIR INHIBITION 
 I was the principal investigator who designed and performed the experiments in 
this chapter, and prepared the associated manuscript that has been submitted to the 
Journal of Virology. Dr. Ranran Wang helped with the cloning of MBP-tagged SV40 sT 
and assisted in some experiments that were not included in the manuscript. Dr. Eiko 
Nakamaru-Ogiso processed the purified sT proteins for and analyzed the data from 
electron paramagnetic resonance analysis. Dr. Simon A. B. Knight helped with the design 
of some experiments. Dr. Christopher B. Buck was of great help with the critique of the 
manuscript and helped with generating the figure for polyomavirus sT alignment. 
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3.1: Chapter Summary 
MCPyV sT antigen has emerged as the key oncogenic driver in MCC 
carcinogenesis. It has also been shown to promote MCPyV LT-mediated viral replication 
by stabilizing LT. The importance of MCPyV sT led me to investigate sT functions and 
to identify potential ways to target this protein. Serendipitously, I discovered that 
MCPyV sT purified from bacteria contains iron-sulfur (Fe/S) clusters. Utilizing electron 
paramagnetic resonance (EPR) analysis, I found that MCPyV sT coordinates a [2Fe-2S] 
and a [4Fe-4S] cluster. I also observed phenotypic conservation of Fe/S coordination in 
the sT of other polyomaviruses. Since Fe/S clusters are critical co-factors in many nucleic 
acid processing enzymes involved in DNA unwinding and polymerization, my results 
suggested that MCPyV sT might be directly involved in viral replication. Indeed, I 
demonstrated that MCPyV sT enhances LT-mediated replication in a manner that is 
independent of LT stabilization. MCPyV sT translocates to the nuclear foci containing 
actively replicating viral DNA, supporting a direct role for sT in promoting viral 
replication. Mutations of Fe/S cluster-coordinating cysteines in MCPyV sT abolish its 
ability to stimulate viral replication. Moreover, treatment with cidofovir, a broad-
spectrum antiviral agent, robustly inhibits the sT-mediated enhancement of MCPyV 
DNA replication but has little effect on the basal viral replication driven by LT alone. 
This finding further indicates that MCPyV sT plays a direct role in stimulating viral DNA 
replication and introduces cidofovir as a possible drug for controlling MCPyV infection. 
 
3.2: Introduction 
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Accumulating evidence has suggested a role for MCPyV in the development of 
the lethal skin cancer MCC, making it the first polyomavirus to be conclusively 
associated with human cancer (6). MCC tumors develop rapidly and are highly 
metastatic. It is one of the most aggressive skin cancers with a high mortality rate of 33% 
(which exceeds the rate of melanoma) (163), and a 5-year observed survival rate of less 
than 45% (3). High seroprevalence for MCPyV in the adult human population and 
analyses of healthy human skin suggest that MCPyV is a common component of the 
normal skin flora (55, 147). 
MCPyV has a circular, dsDNA genome of ~5kb (31). A NCRR separates the 
early and late regions of the viral genome (31). The NCRR contains the viral Ori and 
bidirectional promoters for viral transcription. The early region encodes LT, sT, the 57kT 
antigen, and a recently discovered protein called ALTO (10, 31). The late region encodes 
the capsid proteins, VP1 and VP2 (56, 148). It is well-established that clonal integration 
of the MCPyV genome into the host genome is a key event in the development of 
MCPyV-associated MCC tumors (17). Integration or other mutagenic events almost 
invariably result in the truncation upstream of the C-terminal helicase domain of LT, 
rendering the protein defective for mediating viral replication (17). Although both LT and 
sT antigens are often required for MCPyV-positive MCC cell survival and proliferation 
(27, 41), sT has emerged as the key oncogenic driver in MCC carcinogenesis. This is 
supported by the observation that sT expression can transform rodent fibroblasts, whereas 
expression of LT, or truncated LT found in MCC tumors, alone cannot (41). MCPyV sT 
also demonstrates robust transforming activity in transgenic mouse model systems (43). 
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Due to differential splicing, LT and sT share an N-terminal domain with 
homology to cellular DnaJ chaperone proteins. In sT, the DnaJ motif is followed by a sT-
unique C-terminal domain that has been shown to interact with cellular PP2A 
phosphatases (164). The interaction between PP2A and the well-studied SV40 sT 
contributes to cellular transformation by preventing PP2A-mediated dephosphorylation of 
Akt, resulting in the constitutive activation of the mTOR pathway (44, 45). In contrast, 
independent of PP2A binding, MCPyV sT acts further downstream of the mTOR 
pathway to induce hyper-phosphorylation of the translation initiation factor eIF4E-BP1. 
This sT activity results in a global stimulation of cap-dependent translation (41). In 
addition, binding of MCPyV sT to PP4C has been implicated in the destabilization of 
microtubules and increased cell motility, possibly contributing to the metastatic nature of 
MCC (48). 
Besides its oncogenic role, MCPyV sT is also important for promoting MCPyV 
LT-mediated viral DNA replication (11, 18). MCPyV LT has an Ori-binding domain that 
recognizes specific pentanucleotides at the viral Ori, subsequently leading to Ori 
unwinding and replication of the viral DNA by host cell polymerases (18). Interestingly, 
for MCPyV (11, 18) and JCPyV (165), the presence of sT dramatically enhances LT- 
mediated DNA replication. It has been shown that MCPyV sT indirectly enhances 
replication by stabilizing LT through binding and inhibition of the E3 ubiquitin ligase 
SCFFbw7 (49). More recent in vivo study has shown that MCPyV sT binding to SCFFbw7 is 
also essential for its transforming activity in transgenic mouse models (43). 
	   64	  
The importance of MCPyV sT in the viral life cycle and its association with 
MCPyV-positive MCC led me to investigate potential ways to target this protein to 
dampen viral growth. Serendipitously, I observed that MCPyV sT proteins expressed and 
purified from bacteria consistently showed a dark brown color, suggesting the possible 
presence of metal ions in the protein. It has been reported that the highly conserved 
cysteines in SV40 sT are organized in two CXCXXC clusters essential for the 
coordination of zinc ions and the stability of the protein (145, 146). However, in vitro 
studies suggested that ions other than zinc could be incorporated into the protein (146). 
By utilizing electron paramagnetic resonance (EPR) analysis, Dr. Eiko Nakamaru-Ogiso 
and I show in this chapter that MCPyV sT expressed in bacteria coordinates two iron-
sulfur (Fe/S) clusters, identifying MCPyV sT as a novel viral Fe/S cluster protein. 
Fe/S clusters are ubiquitous ancient protein co-factors (113-115). Fe/S cluster 
domains play critical roles in many cellular nucleic acid processing enzymes, including 
those involved in DNA unwinding, endonuclease activity, reduction of ribonucleotides to 
deoxyribonucleotides, and DNA polymerization (115, 119, 121-126). In light of the 
observation that MCPyV sT stimulates LT viral replication (11, 18), I tested how 
mutating the Fe/S cluster-coordinating cysteines in MCPyV sT affects its function in viral 
DNA replication. Using our previously established system to study MCPyV replication in 
cultured cells (104, 166), I demonstrated that MCPyV sT markedly stimulates LT-
mediated viral DNA replication and that the MCPyV sT Fe/S cluster-coordinating 
cysteines are important for this sT function. In this study, I also show that MCPyV sT can 
promote LT-mediated replication without stabilizing LT protein level. Moreover, sT 
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translocates to the sites of actively replicating LT and viral Ori replication foci, 
suggesting a possible direct role of sT in enhancing viral DNA replication. 
A number of published studies have shown that cidofovir (CDV or HPMPC), a 
nucleoside analogue similar to deoxycytidine monophosphate (dCMP), is an effective 
drug against many DNA viruses, including herpes-, adeno-, polyoma-, papilloma-, and 
poxviruses (reviewed in (167)). It is thought that cidofovir can act as a competitive 
inhibitor to natural nucleotide substrates and be incorporated into the newly synthesized 
DNA chain (168). Consecutive incorporation of this analogue can result in DNA chain 
termination. Cidofovir has been shown to be effective at targeting murine polyomavirus 
and SV40 replication in cell culture (169). BKPyV replication is also inhibited upon 
cidofovir treatment (170).  
Interestingly, there is a recent case study on MCPyV-associated Stevens-Johnson 
Syndrome in an immuno-suppressed patient, in which a high viral load of MCPyV was 
cleared, along with the skin lesions, after cidofovir treatment (171). These findings led 
me to investigate how cidofovir affects MCPyV replication at the LT-mediated basal 
level of replication and at the enhanced level of replication stimulated by sT. To our 
surprise, I discovered that cidofovir robustly inhibits the sT-mediated enhancement of 
MCPyV DNA replication but has little effect on the basal level of viral replication driven 
by LT alone. Together, my studies showed that sT sensitizes MCPyV replication to 
cidofovir treatment, suggesting that cidofovir can potentially be used to dampen MCPyV 
infection. 
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3.3: Results 
3.3.1: MCPyV sT is an Fe/S cluster protein 
When I first expressed MCPyV sT as a maltose-binding protein (MBP) fusion in 
E. coli, I noticed that the pellet of sT-expressing bacteria collected after IPTG induction 
showed a striking dark-brown color (Fig. 3.1A), while a control pellet of bacteria 
expressing an unrelated protein fused to MBP was the usual beige color (Fig. 3.1A, 
“MBP-Gyrase”). A possible explanation for the surprising brown color might be the 
presence of Fe/S cluster(s) in MCPyV sT. Because Fe/S clusters are sensitive to 
oxidation, I performed sT purification and related experiments under semi-anaerobic 
conditions in which all solutions were degassed and purged with oxygen-free nitrogen 
before use. Interestingly, the white amylose resin used to purify MBP-tagged fusion 
proteins turned brown after incubation with sT-containing lysate (Fig. 3.1A, “Bound 
MBP-sT”). This brown-colored resin returned to white when the bound MBP-sT was 
eluted off the resin upon the addition of maltose (Fig. 3.1A, “Eluted MBP- sT”). After the 
eluted MBP-sT was concentrated, it showed a dark brown color (Fig. 3.1A, “Purified 
MBP-sT”). Coomassie staining and western blotting confirmed that MCPyV sT is the 
major protein present in the purified sample (Fig. 3.1B). Furthermore, the intensity of the 
brown color is proportional to the MBP-sT protein concentration, affirming that sT is 
indeed the source of this color. In contrast, the MBP tag purified in the same manner and 
concentrated to the same concentration was colorless (see below). A 6His-tagged protein 
encoding the common “DnaJ” domain of MCPyV sT and LT (residues 1-78) was also 
colorless (data not shown). UV-visible absorption spectrum of the purified brown full-
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length sT exhibited broad 325/420nm absorbance peaks, which was quenched by 
reduction with sodium dithionite (Fig. 3.1C). The unique absorption spectrum of the 
purified MCPyV sT and its sensitivity to dithionite reduction suggest the likely presence 
of Fe/S cluster(s) in MCPyV sT. To confirm this, Dr. Eiko Nakamaru-Ogiso employed 
the EPR technique, which not only can show definitely the presence of Fe/S cluster(s), 
but also identify the type(s) of cluster present in the protein. 
At 12 K and 1 mW, the reduced MCPyV sT protein showed EPR signals 
characteristic of a [4Fe-4S] cluster (Fig. 3.2A). At higher temperatures (40 K) with 
microwave power at 5 mW, the dithionite-reduced protein exhibited a new EPR signal at 
g = 2.015, together with the overlapped EPR signals from a [4Fe-4S] cluster (Fig. 3.2B). 
Since this new signal was barely detectable at lower temperatures, the signal is highly 
likely a [2Fe-2S] cluster, which has a slower relaxation time compared to a [4Fe-4S] 
cluster. These EPR data strongly suggest the presence of two separate Fe/S clusters in 
MCPyV sT. 
3.3.2: MCPyV sT contains a [2Fe-2S] and a [4Fe-4S] cluster 
Fe/S clusters are typically integrated into proteins via tetrahedral coordination of 
iron atoms by cysteine residues (113, 114). To identify candidate Fe/S cluster binding 
motifs in MCPyV sT, I aligned the amino acid sequences of mammalian polyomavirus sT 
proteins. From this analysis, I identified a number of highly conserved residues near the 
sT-unique C-terminal half of the proteins, including two CXCXXC motifs that are 
reminiscent of known Fe/S cluster-coordinating motifs (172). I designated these motifs 
CA (for CACISC in MCPyV sT) and CF (for CFCYQC in MCPyV sT) (Fig. 3.3). In 
	   68	  
addition to the CXCXXC motifs, I also identified C109 and H130 as highly conserved 
residues that might be involved in Fe/S cluster coordination (Fig. 3.3). Although these 
CXCXXC cysteine motifs in SV40 sT have been proposed to line two distinct Zn binding 
pockets (173), in vitro studies suggested that sT may bind other metal ions as well (146). 
Furthermore, some bona fide Fe/S cluster proteins are known to be capable of binding Zn 
in place of the Fe/S cluster (reviewed in (174)). Modeling of MCPyV sT structure using 
Phyre2 (175) and PyMOL (176) showed that the cysteine residues in the CA (C119, 
C121, and C124) and CF (C147, C149, C152) clusters point toward each other to form 
pocket-like structures (see Chapter 4). The modeling results and my data of UV-visible 
spectra and EPR analysis are consistent with the idea that the predicted CA and CF 
motifs in MCPyV sT might function as Fe/S cluster-binding pockets. 
Dr. Eiko Nakamaru-Ogiso and I then performed mutagenesis and EPR analysis to 
identify ligands for the [2Fe-2S] and [4Fe-4S] clusters present in MCPyV sT. As shown 
in Fig. 3.3B, I generated a variety of MCPyV sT mutants in which conserved cysteine(s) 
and/or histidine residues were replaced with alanine. In the CA mutant, C119, C121, and 
C124 were mutated to alanines, while in the CF mutant, C147, C149, and C152 were 
mutated to alanines. The CAF mutant contains six mutations in which all of the cysteines 
in the CA and CF clusters were mutated to alanines. The MBP-tagged CA and CF 
mutants were expressed at levels similar to wild-type sT in E. coli but the purified mutant 
proteins both showed partially reduced brown color compared to wild-type sT (data not 
shown). UV-visible spectra of these two cluster mutants had similar characteristics and 
sensitivity to dithionite reduction as the wild-type MCPyV sT (data not shown), 
suggesting that the CA and CF mutants still contain Fe/S clusters. In contrast, the CAF 
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mutant protein was entirely colorless and was expressed at a much lower level than wild-
type sT in E. coli. 
The EPR spectra showed that the CA and CF mutants likely lost a [2Fe-2S] 
cluster and a [4Fe-4S] cluster, respectively (Fig. 3.4A (a-b)). Using the EPR spectra of 
CA and CF mutants carrying a single Fe/S cluster, we were able to perform spin 
simulation and obtain the g values of each cluster. The CF cluster seen in the CA mutant 
is a [4Fe-4S] cluster with the g values of gz,y,x = 1.989, 1.930, 1.915 (Fig. 3.4A (c)), while 
the CA cluster seen in the CF mutant is a [2Fe-2S] cluster with the g values of gz,y,x = 
2.015, 2.005, 1.91 (Fig. 3.4A (d)). 
Introduction of a C109A mutation into the wild-type or CA mutant MCPyV sT 
led to a drastic reduction and a shift in the EPR signals of the [4Fe-4S] cluster occupying 
the CF pocket (Fig. 3.4B). At face value, this might seem to suggest that MCPyV sT 
C109 might be involved in coordinating the tetrahedral CF pocket. However, the C109A 
mutation also partially destabilized the CA cluster in the wild-type sT (i.e., the g = 2.015 
signal disappeared in the C109A/WT mutant) (Fig. 3.4C, top). The CA cluster signal was 
further diminished in the EPR spectra of the C109A/CF mutant, although the gz and gy 
signals of the CA cluster were still recognizable (Fig. 3.4C, bottom). It seems possible 
that C109 is not specifically essential for either the CA or the CF pocket and the mutation 
might instead simply cause global misfolding of the protein, which led to distortion of 
both CA and CF clusters. An alternative hypothesis is that, in MCPyV sT, the poorly 
conserved C104 forms the apex of the CA pocket. This hypothesis is consistent with the 
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fact that the homologous residue in SV40 sT, C97, falls very close to the apex of the CA 
pocket. 
In SV40 sT, the tetrahedral apex of CF pocket involves a highly conserved 
histidine residue homologous to H130 in MCPyV. Introducing the H130A mutation into 
the wild-type or CA mutant did not cause any major spectral change (Fig. 3.4B), 
suggesting that the H130 residue is not involved in the coordination of the CF cluster. 
Although an H130A mutation slightly changed the shape of the gz and gx signals of CA 
cluster, the EPR signal for the [2Fe-2S] cluster associated with the CA pocket remained 
strong in the H130A/WT and H130A/CF mutants (Fig. 3.4C). This suggests that H130 is 
not essential for the coordination of the CA cluster either. An alternative possibility is 
that C131 (which is conserved only in MCPyV and a few closely related polyomavirus 
species) forms the tetrahedral apex of the CF cluster in MCPyV sT. Based on comparison 
to the SV40 sT crystal structure, the partially conserved C141 in MCPyV (homologous to 
P132 in SV40) might also be a candidate for the fourth tetrahedral coordinating residue of 
the CF pocket. X-ray crystallography of MCPyV sT is likely needed to resolve this 
question. Taken together, the data suggest that MCPyV sT contains one [2Fe-2S] 
coordinated with C119, C121, C124, and an unknown fourth residue, and one [4Fe-4S] 
cluster coordinated with C147, C149, C152, and an unknown fourth residue. 
3.3.3: Mutation of the Fe/S cluster-coordinating cysteines in MCPyV sT abolishes its 
ability to stimulate LT-mediated viral DNA replication 
A variety of Fe/S proteins are involved in many aspects of nucleic acid 
metabolism such as DNA replication, DNA repair, recombination, and gene transcription 
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(115). The specific roles of Fe/S clusters include electron transport, sensing oxidative 
stress, detecting DNA damage, stabilizing protein structure, forming enzymatic active 
sites, and functioning as regulatory cofactors (115, 121, 177). I therefore set out to 
examine the possible physiological significance of MCPyV sT Fe/S clusters. The Fe/S 
cluster domain has been proposed to act as part of a molecular ‘‘plowshare’’ in 
unwinding DNA duplex to support the function of many DNA helicases (123-125, 127, 
129, 130). Because of the possible sT function in stimulating LT-mediated viral 
replication (18), I speculated that sT Fe/S clusters might play direct mechanistic roles to 
promote LT mediated viral DNA replication. To test this, I co-transfected C33A cells 
with a construct encoding wild-type MCPyV sT or the Fe/S mutants, a plasmid encoding 
MCPyV LT, and a plasmid carrying the MCPyV replication Ori. I then analyzed the 
effect of sT expression on LT-mediated MCPyV Ori+ plasmid replication, as described 
previously (104, 166). While expression of LT alone can drive replication of the Ori+ 
plasmid, the level of replication was significantly enhanced in the presence of wild-type 
sT (Fig. 3.5A, “Newly- synthesized DNA”). This is consistent with previous reports 
showing that sT has the ability to promote viral replication (18). Interestingly, the CA, 
CF, and CAF cluster mutants all lost their ability to stimulate LT-mediated replication, 
even though they were expressed at nearly the same level as wild-type sT (Fig. 3.5). The 
amount of replicated Ori plasmid detected in the presence of these mutants was reduced 
to the basal level supported by LT-only (Fig. 3.5A). I also blotted for GFP, which is 
expressed from the SV40 promoter in the sT vectors to confirm similar transfection 
efficiency in all of the samples (Fig. 3.5B, “GFP”). This experiment was repeated in 
HEK293 cells and similar results were observed, although the Fe/S mutants were 
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expressed at a lower level compared to the C33A experiment (data not shown). The 
results suggest that the presence of Fe/S clusters may be essential for the ability of sT to 
stimulate MCPyV replication. 
It has been reported previously that sT can stabilize LT by interfering with the 
interaction between LT and the cellular ubiquitin ligase SCFFbw7 (49). In this scenario, sT 
might enhance replication simply by increasing the abundance of LT. However, in my 
C33A replication system, I did not detect any stabilization of LT in the presence of sT 
(Fig. 3.5B). My studies therefore show that, in some cell lines, the ability of sT to 
enhance viral DNA replication is independent of its ability to stabilize LT. 
3.3.4: MCPyV sT translocates to LT/Ori replication factories in cells 
To further explore the idea that sT plays a direct role in viral DNA replication, I 
tested the subcellular localization of sT to determine if it could be part of the LT/Ori 
replication complexes that our lab has described in previous studies (104, 166). I first 
transfected C33A cells with a plasmid encoding Xpress-tagged sT and observed a diffuse 
staining pattern in the nucleus (Fig. 3.6A, top panel). This diffuse staining of sT was also 
seen when C33A cells were co-transfected with the sT plasmid and the MCPyV Ori 
plasmid (Fig. 3.6A, bottom panel). This is expected, since sT does not have an Ori-
binding domain and it has been shown to lack the capacity to drive replication of viral 
DNA when expressed alone (18). 
MCPyV LT-mediated replication complexes can be observed in cells co-
transfected with MCPyV LT and the Ori, as described in previous studies from our lab 
(104, 166). I therefore adopted this LT/Ori co-transfection system in C33A cells to see if 
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sT is recruited to the sites of actively replicating viral Ori. Since the LT CM2B4 antibody 
and the anti-Xpress antibody that could recognize tagged-sT are both mouse antibodies, I 
could not perform double staining for colocalization analysis using these two antibodies. 
I therefore decided to examine if sT colocalizes with the MCPyV LT/Ori replication 
factories by performing immunofluorescent staining of MCPyV sT and either RPA70, a 
host protein required for the stabilization of ssDNA during polyomavirus replication, or 
ATR, a host DNA damage response factor important for optimal MCPyV replication 
(166). Both of these factors have been used in my previous studies to visualize the 
actively replicating MCPyV LT/Ori complexes (166). 
Interestingly, in the presence of LT-mediated replication (as marked by the 
formation of nuclear foci with RPA70 or ATR), sT translocated to the putative sites of 
active viral DNA replication (Fig. 3.6B). The change in the subcellular localization of sT 
from a diffuse nuclear pattern to a punctate staining pattern showing colocalization with 
host factors involved in MCPyV replication suggests a possible direct role of sT in 
promoting viral replication. 
3.3.5: Enhancement of MCPyV LT-mediated replication by sT is abolished upon 
cidofovir treatment 
Cidofovir is a potent inhibitor of polyomavirus replication (169, 170, 178). 
Although its active metabolite, cidofovir diphosphate, is known to inhibit viral DNA 
replication by selectively inhibiting virally encoded DNA polymerases, polyomaviruses 
do not encode any polymerases. Thus, the mode of action of cidofovir against 
polyomaviruses remains entirely unknown. To test how cidofovir affects MCPyV DNA 
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replication in the presence and absence of sT, I co-transfected C33A cells with a plasmid 
encoding MCPyV LT, a plasmid encoding MCPyV sT, and a plasmid carrying the 
MCPyV Ori. At 24 hpt, the cells were treated with increasing doses of cidofovir for 
another 24 h (Fig. 3.7). In the absence of sT, LT-mediated replication remained at a 
steady, basal level and was only slightly inhibited by the highest concentration of 
cidofovir tested (Fig. 3.7A, “Newly-synthesized DNA”). Intriguingly, a dramatic 
cidofovir dose-dependent reduction of Ori+ plasmid replication was seen in the presence 
of sT (Fig. 3.7A and B). Cidofovir treatment did not affect LT and sT expression levels 
(Fig. 3.7C). The results show that cidofovir specifically inhibits the sT-mediated 
enhancement of MCPyV DNA replication and has little effect on the basal viral DNA 
replication induced by LT alone. The findings confirm that MCPyV sT plays a cidofovir-
sensitive direct role in stimulating viral DNA replication. 
3.3.6: MCPyV sT coordinates more stable Fe/S clusters than other sT proteins 
Our EPR analysis shows that MCPyV sT is a Fe/S cluster protein (Fig. 3.2 and 
3.4). Since the cysteines essential for coordinating the [2Fe-2S] and [4Fe-4S] clusters are 
highly conserved among human polyomavirus sTs (Fig. 3.3), I investigated whether the 
Fe/S cluster features seen in MCPyV sT is also conserved in the recently discovered 
human polyomavirus 7 (HPyV7) (179). I chose to test the sT of this polyomavirus 
because it has recently been shown to be associated with thymic tumors (180) and with 
pruritic skin rashes seen in immunosuppressed transplant patients (181). HPyV7 sT not 
only contains the conserved Fe/S cluster-coordinating cysteine motifs (Fig. 3.3), but also 
showed dark brown color when purified from E. coli as an MBP fusion (data not shown). 
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These observations suggest that HPyV7 sT also carries Fe/S cluster(s). In addition, MBP-
tagged HPyV7 sT expressed in and purified from E. coli produced a similar UV-visible 
spectrum as MBP-MCPyV sT (Fig. 3.8A). The characteristic shoulder around 350 nm 
and a peak at around 420 nm suggest the presence of Fe/S cluster(s) in this protein (Fig. 
3.8A). However, UV-visible absorption spectrum of the purified HPyV7 sT consistently 
showed dramatically reduced absorbance at the characteristic Fe/S cluster 325/420nm 
peaks compared to MCPyV sT (Fig. 3.8A), even though the expression level and 
purification efficiency of MBP-MCPyV sT and MBP-HPyV7 sT were comparable (Fig. 
3.8B). Compared to MCPyV sT, I also detected a much lower Fe/S cluster associated 
325/420nm absorbance in the sTs of HPyV6 and SV40 (Fig. 3.8C and D). The results 
suggest that, although all of the sTs shown in Fig. 3.3 carry the same cysteine sequence 
motifs for Fe/S cluster binding, the Fe/S clusters in MCPyV sT expressed in bacteria are 
more stable compared to the ones in other polyomavirus sTs. 
 
3.4: Discussion  
The link between MCPyV and MCC opens a new avenue for investigating how 
polyomaviruses induce cancer. A vital question in MCPyV research has been how the 
virally encoded proteins regulate the viral life cycle and, in rare cases, trigger MCC 
development. While studies on LT have mostly been focused on its role in viral 
replication, studies on sT cover a number of stages in the viral life cycle and associated 
tumorigenesis, reflecting the important role of this protein plays in the biology of the 
virus and human cancer. Our previous effort in studying the host factors required for 
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efficient MCPyV DNA amplification has established a platform for us to investigate the 
roles of other proteins involved in replication (104, 166). In this chapter, I aimed to better 
understand the nature of MCPyV sT function and to target this protein in an effort to 
dampen viral growth. 
I discovered that MCPyV sT purified under semi-anaerobic conditions from 
bacteria contains Fe/S clusters (Fig. 3.1-4). Sequence analysis identified two CXCXXC 
Fe/S cluster-coordinating motifs in the sT-unique C-terminal half of MCPyV sT (Fig. 
3.3). Our EPR analysis provides definitive evidence for the presence of a [2Fe-2S] and a 
[4Fe-4S] cluster in MCPyV sT (Fig. 3.2 and 3.4). 
We note that the key cysteine motifs required for MCPyV sT incorporation of 
Fe/S clusters are well conserved in mammalian polyomaviruses. One minor exception is 
that members of a small clade of 11 species, including the recently discovered 
polyomavirus NJPyV, lack the third cysteine of the CA motif. It is also worth noting that 
the sT proteins of avian polyomaviruses are devoid of conserved cysteine-rich motifs. I 
was able to observe phenotypic conservation of Fe/S clusters in the sT of HPyV6, 7, and 
SV40 (Fig. 3.8). Notably, these sT proteins purified from bacteria all showed a similar 
UV-visible spectrum as MCPyV sT, but at a much lower intensity. These interesting 
observations suggest the possibility that the Fe/S clusters coordinated by these sTs may 
have different sensitivities to oxygen oxidation, with the MCPyV sT Fe/S clusters 
displaying the highest stability. This result also implies that, although the sTs shown in 
Fig. 3.3 carry the same highly conserved cysteine sequence motifs that are important for 
coordinating Fe/S clusters in MCPyV sT, other variations in the surrounding amino acid 
	   77	  
sequences may render greater oxygen sensitivity of the Fe/S clusters in the sT of HPyV6, 
7, and SV40. This phenomenon has been observed in other Fe/S cluster proteins such as 
the transcriptional regulator FNR, in which a single amino acid replacement near an Fe/S 
cluster-coordinating site leads to a drastic change in its oxygen sensitivity (182-184). The 
strong MCPyV sT Fe/S cluster stability might hypothetically account for its unique 
function in the viral life cycle and cellular transformation established in previous studies 
(41, 43, 47). Future structural analysis and mutagenesis studies would delineate the 
differences between MCPyV sT and the other sTs tested in this study to define the 
molecular details that support the high MCPyV sT Fe/S cluster stability. In addition, 
functional comparison of MCPyV sT and other sTs displaying lower Fe/S cluster stability 
could provide important clues for understanding the unique MCPyV sT biological 
functions established in previous studies (41, 43, 47). 
A previous report from the Chang/Moore group elegantly demonstrates that sT 
boosts MCPyV replication by interacting with the SCFFbw7 E3 ubiquitin ligase, 
consequently stabilizing LT (49). I also observed the MCPyV sT-mediated LT 
stabilization in 293 cells (data not shown). However, in my C33A replication system, 
MCPyV sT is able to enhance LT-mediated DNA amplification without any apparent 
stabilization of LT (Fig. 3.5). It thus appears that the sT-induced LT stabilization is cell 
type-specific. My results also indicate that sT translocates to the foci of actively 
replicating viral DNA in the nucleus (Fig. 3.6), suggesting the possibility of a more direct 
role for sT in promoting viral replication. Many DNA polymerases depend on Fe/S 
clusters for replisome processivity (121, 122). It is possible that sT works in conjunction 
with LT and functions as part of a processive helicase that continues to melting apart 
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and/or extending the replication fork after the initial Ori unwinding and replication fork 
formation induced by MCPyV LT. Future studies will test this model to elucidate the 
mechanisms by which MCPyV sT directly affects the LT-mediated viral DNA 
replication. 
Although cidofovir has long been known to inhibit the replication of 
polyomaviruses in culture, its mechanism of action has remained uncertain (169, 170, 
178). Here, I show that cidofovir can inhibit MCPyV replication. Interestingly, the 
reduction in replication is more dramatic in the presence of sT, while only a modest 
decrease in replication is seen in LT-only basal level of replication (Fig. 3.7). Future 
studies will be needed to investigate whether cidofovir acts directly on sT, inhibits a 
cellular binding partner of sT, or acts directly on LT that has been directly or indirectly 
modified by an sT-dependent activity. In any event, my results show that, when screening 
for MCPyV DNA replication inhibitors, inclusion of MCPyV sT in the replication assay 
would allow detection of a broader spectrum of effective drugs that might be missed if 
the assay only detects the LT-mediated basal level of viral replication. 
We attempted to confirm the presence of Fe/S clusters in sT expressed and 
purified from mammalian cells by performing a colorimetric iron content assay with 
immunoprecipitated sT. However, the measurements for sT were only slightly above the 
negative control (data not shown), likely due to the technical limitation of the assay to 
detect very low iron levels in sT from mammalian cells. Similar technical issues may 
help explain why it has not been possible to directly detect iron in any of the known 
cellular Fe/S cluster proteins purified from mammalian cells (185). Another theoretical 
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explanation might be that sT (and perhaps other mammalian Fe/S cluster proteins) exist 
as a blend of individual molecules carrying either Zn or Fe/S. Of note, the two studies 
that showed radioactive zinc incorporation in SV40 sT purified from bacteria (145, 146) 
were also unable to recapitulate their findings in SV40 sT expressed in mammalian cells 
due to the low level of sT expression. Moreover, many Fe/S clusters in metalloproteins 
are known to be sensitive to oxygen (183). Fe/S clusters can be oxidized during the 
purification process. In fact, we observed [3Fe-4S] cluster signals in the oxidized 
MCPyV sT purified from bacteria. This strongly suggests that Fe/S clusters in MCPyV 
sT are partially oxygen sensitive, since the observed [3Fe-4S] cluster is most likely the 
degradation product of [4Fe-4S] clusters. This oxygen sensitivity could contribute to the 
difficulty in directly detecting iron in the small amount of MCPyV sT expressed in 
mammalian cells. 
In summary, we have found that polyomavirus sTs carry Fe/S clusters and have 
demonstrated that, in MCPyV sT, these clusters are needed for sT-mediated enhancement 
of LT-driven viral DNA replication. The replication enhancement function of sT does not 
appear to involve the stabilization of LT and instead seems likely to be a direct activity, 
since sT colocalizes with viral replication factories. Moreover, I have discovered that 
cidofovir treatment can specifically inhibit sT-enhanced MCPyV replication, suggesting 
that sT sensitizes the cells to cidofovir, possibly at the level of deleterious incorporation 
of the nucleoside analog into the nascent viral DNA strand. This current report provides 
new insights into the biology of MCPyV and introduces possible drug targets for 
controlling MCPyV infection. 
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3.5: Figures  
 
Figure 3.1 
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Figure 3.1   MCPyV sT has characteristics of an Fe/S cluster protein. (A) 
BL21(DE3)pLysS bacteria were transformed with a plasmid encoding MBP-MCPyV sT. 
The fusion protein was expressed upon the addition of IPTG. After 4 hours of induction, 
bacteria were collected. Clarified bacterial lysate was incubated with amylose resin for 2 
hours. Bound proteins were eluted with maltose and then concentrated using Amicon spin 
column. Representative pictures from at least three experiments are shown. (B) Purified 
MCPyV sT (marked by asterisk) was resolved by SDS-PAGE and visualized by 
Coomassie staining and western blotting. (C) UV-visible absorbance spectrum of purified 
MCPyV sT before (solid line) and after (dotted line) dithionite reduction. The Fe/S 
cluster characteristic peak at 420 nm was sensitive to dithionite reduction. 
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Figure 3.2 
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Figure 3.2   EPR spectra of purified wild-type MCPyV sT at 12 K and 1 mW (A) and at 
40 K and 5 mW (B). The sample (17 mg/ml) in 20 mM Tris-HCl at pH 7.4 containing 
200 mM NaCl, 1 mM DTT, 10 mM maltose, and 10% glycerol was reduced with 20 mM 
dithionite. EPR conditions: microwave frequency, 9.45 GHz; modulation amplitude, 6 G; 
modulation frequency, 100 kHz; time constant, 82 ms. Major g values are indicated. 
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Figure 3.3 
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Figure 3.3   Sequence alignment of various polyomavirus sTs. (A) Amino acid sequences 
of selected polyomavirus sTs were obtained from NCBI and aligned using MacVector 13. 
Conserved residues are highlighted with grey shading. The potential CXCXXC Fe/S 
clusters are highlighted in red (CA) and blue (CF) boxes. Boxed cysteines were mutated 
to alanine for subsequent experiments. The cysteine and histidine residues marked with 
asterisks were also mutated to alanine for electron paramagnetic resonance analysis. (B) 
MCPyV sT mutants generated for this study. 
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Figure 3.4 
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Figure 3.4 
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Figure 3.4   (A) EPR spectra of purified CA- and CF-knockout MCPyV sT mutants at 12 
K and 1 mW (a) and at 40 K and 5 mW (b). Black, red, and blue lines are the data from 
the wild-type (17 mg/ml), CA (14 mg/ml), CF (11 mg/ml) mutant samples, respectively. 
The simulated spectra of the CF cluster in the CA mutant and CA cluster in the CF 
mutant are shown in (c) and (d), respectively, with principal g values. (B and C) The 
effects of additional mutations at conserved C109 and H130 residues on the EPR spectra 
of the wild-type (WT), CA-, and CF-knockout mutants. EPR spectra were recorded at 12 
K and 1 mW (B) and at 40 K and 5 mW (C). Red, thin red, blue lines are the data from 
the samples that H130A, H130C, or C109A mutations were introduced in the wild-type 
(Fig. 3.4B and 3.4C, upper panels) or CA- and CF-knockouts (Fig. 3.4B and Fig. 3.4C, 
lower panels), respectively. For comparison, the same data of the wild-type, CA-, and 
CF-knockouts shown in Fig. 3.4A are added as dotted black, dotted red, dotted blue lines, 
respectively. Other EPR conditions are the same as described in Fig. 3.2. 
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Figure 3.5 
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Figure 3.5   Mutation of the Fe/S cluster-coordinating cysteines in MCPyV sT abolishes 
its ability to enhance LT-mediated viral DNA replication. (A) C33A cells were co-
transfected with plasmids encoding MCPyV LT, sT as indicated, and a plasmid carrying 
the MCPyV Ori. At 48 hpt, total cellular DNA was extracted for Southern blotting to 
analyze the Ori plasmid. 15 µg of DNA was digested with BamHI and DpnI to detect 
newly-replicated DNA, while 2 µg of DNA was digested with only BamHI to show equal 
loading. (B) Total protein extractions were used in western blotting to detect MCPyV LT, 
sT, and actin. GFP was blotted as a transfection control for the sT plasmid. 
Representative data from three experiments are shown. 
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Figure 3.6 
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Figure 3.6   MCPyV sT translocates to viral DNA replication factories in the presence of 
the viral Ori and LT. (A) C33A cells were co-transfected with a plasmid encoding 
Xpress-tagged wild-type sT and a plasmid carrying the MCPyV Ori as indicated. At 48 
hpt, cells were stained for Xpress (green). The cells were counterstained with DAPI. (B) 
C33A cells were co-transfected with a plasmid encoding Xpress-tagged wild-type sT, a 
plasmid encoding LT, and a plasmid carrying the MCPyV Ori. At 48 hpt, cells were 
stained for Xpress (green) and the DNA damage response proteins (red) as indicated. The 
cells were counterstained with DAPI. The DNA damage response protein staining was 
used to mark the MCPyV DNA replication complexes. Representative pictures from at 
least three experiments are shown.  
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Figure 3.7 
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Figure 3.7   Enhancement of MCPyV LT-mediated viral DNA replication by sT is 
abolished upon cidofovir treatment. (A) C33A cells were co-transfected with a plasmid 
encoding MCPyV LT, a plasmid carrying the MCPyV Ori, and either the vector control 
(Vec) or wild-type sT. At 24 hpt, increasing amount of cidofovir (CDV) was added as 
indicated. At 48 hpt, total cellular DNA was extracted for Southern blotting. 15 µg of 
DNA was digested with BamHI and DpnI to detect newly-replicated DNA, while 2 µg of 
DNA was digested with only BamHI to show equal loading. (B) Quantification of the 
replicated DNA bands. The value from no drug control was arbitrarily set to 1. Data 
represent means and the standard error of the mean from three experiments. (C) Total 
protein extractions were used in western blotting to detect MCPyV LT, sT, and actin. 
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Figure 3.8 
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Figure 3.8   MCPyV sT coordinates more stable Fe/S clusters than other sT proteins. (A) 
MBP tag (negative control), MBP-MCPyV sT, and MBP-HPyV7 sT were purified as 
described in Fig. 3.1. The UV-visible spectra of the purified proteins were measured and 
normalized to their respective protein concentration. Representative data from three 
experiments are shown. (B) Purified proteins (marked by asterisks) were resolved by 
SDS-PAGE and visualized by Coomassie staining. (C) MBP-MCPyV sT, MBP-SV40 sT, 
and MBP-HPyV6 sT were purified as described in Fig 3.1. The UV-visible spectra of the 
purified proteins were measured and normalized to their respective protein concentration. 
Representative data from two experiments are shown. (D) Purified proteins (marked by 
asterisks) were resolved by SDS-PAGE and visualized by Coomassie staining. 
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CHAPTER 4: CONTINUING INVESTIGATION ON THE ROLES OF MERKEL 
CELL POLYOMAVIRUS LARGE AND SMALL TUMOR ANTIGENS IN VIRAL 
REPLICATION 
 Using the MCPyV replication system we have established in the lab, I have 
shown the importance of the host DDR machinery in MCPyV replication, and that the 
MCPyV sT Fe/S cluster-coordinating ability is important to support MCPyV LT-
mediated viral replication. However, the findings presented in the earlier chapters leave 
some important questions that demand further investigation, particularly regarding the 
mechanisms by which sT enhances LT-mediated replication. In this chapter, I discuss 
additional experiments performed in attempt to address some of these remaining 
questions. 
 
 
 
 
 
 
 
 
 
Some of the data presented are included in the MCPyV sT manuscript described in 
Chapter 3. The rest of the data is prelimary but is essential for the continuation of the 
study on MCPyV LT and sT.  
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4.1: Modeling of MCPyV sT Structure 
 Identification of MCPyV sT as a novel Fe/S cluster protein opens new doors to 
the understanding of the structure and functionality of this protein. As mentioned in 
Chapter 3, there are several cysteines that are highly conserved among polyomaviruses 
sTs. Six of these cysteines are organized into two CXCXXC cysteine motifs near the 
unique C-terminal half of sT. Earlier in vitro studies on SV40 sT have suggested that the 
motifs are responsible for the coordination of two zinc ions, and that mutations of these 
cysteines render the protein unstable, suggesting that the metal cofactor is at least 
important for protein structure/stability (145, 146). Although the crystal structure of 
SV40 sT elegantly shows the coordination of two zinc ions in sT (173), it remains 
possible that other metal ions could be incorporated as well. While my EPR data in 
Chapter 3 does not rule out the presence of zinc in MCPyV sT, it definitively 
demonstrates the presence of two Fe/S clusters in sT.  
 To better understand how it is possible for MCPyV sT to coordinate two Fe/S 
clusters, I modelled its structure using Phyre2 (175) and PyMOL (176) (Fig. 4.1). 
Interestingly, I note that the cysteines of the CA cluster (C119, C121, and C124) and the 
ones of the CF cluster (C147, C149, and C152) point towards each other, forming two 
pocket-like structures capable of binding Fe/S clusters. Various sT mutants were 
generated (see Chapter 3, Fig. 3.3, and data not shown) in order to determine the 
additional residues important for coordinating the two Fe/S clusters. However, based on 
our EPR analysis (see Chapter 3, Fig. 3.4), the mutation of the well-conserved C109 
distorts both the CA and CF clusters, and the mutation of the well-conserved H130 does 
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not seem to affect the coordination of the two clusters. For that reason, the fourth ligand 
for each of the cluster remains to be identified. Since my findings have triggered 
excitement in the effort in crystallizing MCPyV sT, I initiated a collaboration with Dr. 
Thilo Stehle at the University of Tübingen in Germany for X-ray crystallography. We 
believe crystallization of MCPyV sT is needed to resolve the structural details of this 
protein, which is essential for understanding sT’s functions in the MCPyV life cycle.  
 
4.2: Evidence from Mammalian Cells Supports the Presence of Fe/S Clusters in 
MCPyV sT 
As mentioned in the Introduction, EPR and Mössbauer spectroscopy are powerful 
techniques that allow researchers to detect the presence and identify the types of Fe/S 
clusters in proteins. Although the EPR analysis on MCPyV sT definitively shows the 
presence of two Fe/S clusters in sT expressed in E. coli, it is not known whether sT 
expressed in mammalian cells also coordinates Fe/S clusters or that the incorporation of 
Fe/S clusters is simply an artifact of an over-expression system in bacteria. 
 Due to the low level of protein expression in mammalian cells, it is not possible to 
employ the EPR technique to analyze MCPyV sT expressed in cultured cells. This is a 
common technical limitation in the Fe/S cluster protein research field (118, 185), and 
researchers tend to over-express their protein of interest in bacteria or yeast to detect the 
presence of Fe/S clusters. In order to obtain supportive evidence in mammalian cell 
cultured system, with the help of Dr. Simon A. B. Knight (University of Pennsylvania), I 
transfected HEK293 cells with either the vector control or a plasmid encoding MCPyV 
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sT fused to two IgG binding domains of Staphylococcus aureus protein A (sT-TII). The 
cells were treated with deferoxamine (DFO), an iron chelator, to deplete iron in the 
media, followed by incubation with radioactive 55Fe. I then lysed the cells and purified 
MCPyV sT on IgG beads and measured the amount of 55Fe incorporated by liquid 
scintillation counting. I detected five-fold higher signal in the immunoprecipitates of sT-
transfected cells compared to control vector-transfected cells (Fig. 4.2A). Efficient 
purification of sT was confirmed by western blotting (Fig. 4.2B). Although I cannot rule 
out the possibility that MCPyV sT co-purifies with a cellular binding partner that is also a 
Fe/S cluster protein, in light of the evidence obtained from MCPyV sT expressed in E. 
coli, this finding is consistent with the conclusion that MCPyV sT expressed in 
mammalian cells also coordinates Fe/S clusters. 
 
4.3: Effects of Iron Depletion on MCPyV Replication 
 Iron uptake and the biogenesis of Fe/S cluster proteins are tightly regulated 
processes in the cell (114, 120). Since my data shows that MCPyV sT is a Fe/S cluster 
protein, and that it plays an important role in viral replication, it is important to ask how 
depletion of iron in the cell would affect sT and its function in MCPyV replication.  
In an effort to answer this question, as suggested by my Thesis Committee, I 
performed a replication experiment in which the cells were fetal bovine serum (FBS)-
starved to reduce iron uptake. C33A cells were co-transfected with a plasmid encoding 
MCPyV LT, the plasmid carrying the viral Ori, and a vector control or a plasmid 
encoding wild-type sT (Fig. 4.3). Complete culture media was replaced with FBS-free 
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media at various timepoints. However, regardless of the presence of sT, LT-mediated 
replication was inhibited by FBS starvation (Fig. 4.3A, “Newly-synthesized DNA”). The 
severity of the effect correlates with the duration of FBS depletion, i.e. the longer the 
cells were FBS-starved, the less replication observed. This is not likely due to an impact 
on protein level as FBS depletion had minimal effect on LT and sT expression (Fig. 
4.3B).  
One possible explanation is that the FBS depletion was too harsh for the cells and 
that the lack of iron (and many other nutrients) was inhibiting host cell cycle progression 
and shutting down the cellular replication machinery. Consequently, regardless of the 
presence of sT, we observed a reduction in viral DNA replication. Future experiments 
using the iron chelator DFO or knocking down factors of the Fe/S cluster assembly 
machinery may be able to address this question without having too drastic of an effect on 
global cellular replication. However, as mentioned in the Introduction, various cellular 
proteins involved in DNA replication are, in fact, Fe/S cluster proteins. Therefore, even if 
I could specifically deplete iron from the cells, it might still be affecting general cellular 
replication.  
 
4.4: Physical Interaction between MCPyV LT and sT 
 The observation from Chapter 3 showing the relocalization of MCPyV sT in the 
presence of LT/Ori replication complexes leads to one obvious question: How is sT 
recruited to the sites of LT-mediated replication? Since there is no Ori-binding domain on 
sT, it is not plausible for sT to recognize and bind to the Ori plasmid. To date, there is no 
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report on sT directly binding to proteins involved in MCPyV replication. Therefore, I set 
out to test whether MCPyV LT could physically interact with sT by co-
immunoprecipitation.  
 I transfected HEK293 cells with a plasmid encoding MCPyV LT fused to two IgG 
binding domains of Staphylococcus aureus protein A through a tobacco etch virus (TEV) 
protease cleavage site (IIT-tagged LT) and either the vector control or a plasmid 
encoding wild-type sT (Fig. 4.4). As noted in the “Input,” LT expression is stabilized by 
the presence of sT, as reported previously (49). Purification of IIT-LT using IgG beads 
was efficient, however, no sT was detected in the pulldown sample (Fig. 4.4, “IP”). It is 
possible that sT could bind to LT, but only when LT is engaged in the replication 
complexes. To test this hypothesis, I added the MCPyV Ori plasmid during 
immunoprecipitation, in an effort to recapitulate the formation of LT/Ori complexes in 
vitro. However, sT was not co-purifed with LT either in the presence of the Ori or the 
control vector. This data suggests that MCPyV LT and sT do not physically interact.  
 I have performed various co-immunoprecipitation experiments to test for the 
interaction between LT and sT. Reciprocal immunoprecipitation of IIT-tagged sT did not 
pull down LT (data not shown). Of note, this experiment has a caveat: The input level of 
LT is not the same in the control sample versus the sample with sT expression because sT 
stabilizes LT. To avoid this problem, I have also tried purifying either IIT-LT or IIT-sT 
on beads, and incubating the beads with lysates from cells expressing either sT or LT, 
respectively (data not shown). However, I did not detect any interaction between LT and 
sT. To ensure that the potential interaction between LT and sT is not limited by the 
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amount of these proteins expressed in mammalian cells, I performed co-
immunoprecipitation experiments with LT and sT expressed from E. coli (data not 
shown). Again, none of these experiments yielded any positive interactions between 
MCPyV LT and sT. It is, therefore, possible that sT is recruited to the viral replication 
complexes via its interaction with other factors involved in replication instead. 
 
4.5: Binding of MCPyV LT to the Viral Ori in the Presence of sT 
 It has been reported that MCPyV sT can stabilizes LT by binding to and inhibiting 
the ubiquitin ligase SCFFbw7, indirectly enhancing viral replication (49). However, the 
fact that sT translocates to the sites of LT-mediated replication (see Chapter 3, Fig. 3.6) 
suggests a more direct role of sT in replication. In addition, as mentioned in the 
Introduction, for the rotavirus NSP5 Fe/S cluster protein, preliminary data suggest that 
the cluster modulates the binding affinity of NSP5 for RNA (144). These data led me to 
test whether the affinity of LT for the viral Ori is regulated by sT. It is possible that sT 
enhances viral replication by increasing LT/Ori binding affinity.  
 To address this question, I performed the NoShift assay, which is a colorimetric 
assay-based alternative to electrophoretic mobility shift assays (EMSAs). Briefly, using 
the Ori sequence identical to the one used in my Southern blot experiments, I first 
synthesized the MCPyV Ori oligos with both strands labeled with biotin on the 3’-end. 
The oligos were then hybridized to form annealed biotinylated duplexes, which were 
incubated with protein extracts from cells expressing LT and/or sT. The binding reactions 
were subsequently loaded onto a streptavidin-coated plate to isolate oligos-bound 
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complexes. After washing away unbound oligos and proteins, the presence of bound LT 
was detected by the CM2B4 antibody that recognizes MCPyV LT but not sT. The signal 
was then amplified by the addition of a secondary antibody conjugated with horseradish 
peroxidase. Upon the addition of 3,3',5,5'-tetramethylbenzidine (TMB) substrate, a 
colorimetric signal was developed. The reactions were quenched by the addition of 
hydrochloric acid and the absorbance readings at 450 nm, corresponding to the amount of 
LT present on the bound oligos, were read.  
 In the initial experiment, I tested whether the NoShift assay was a specific and 
sensitive alternative to EMSA for detecting LT and Ori interaction. I transfected HEK293 
cells with a vector control (ctrl) or a plasmid encoding MCPyV LT (Fig. 4.5A). Since LT 
is mainly found in the nucleus, I harvested the nuclear extracts (NE) for NoShift assay. 
Increasing amount of LT NE was incubated with the Ori oligos. Interestingly, I observed 
increasing signal in a LT NE dose-dependent manner (Fig. 4.5A). The signal was not due 
to non-specific binding of LT NE to the streptavidin plate because only background level 
of signal was detected in the absence of the Ori (Fig. 4.5A, “No Ori + 4x LT NE”). In 
addition, the binding reaction with Ori mixed with ctrl NE only showed background level 
of signal (Fig. 4.5A, “Ori + 4x ctrl NE”), suggesting that the signal was indeed specific 
for LT/Ori binding. This experiment gave me the confidence to use the NoShift assay to 
test for sT’s effect on LT/Ori binding.  
 I then transfected HEK293 cells with a vector control (ctrl) or a plasmid encoding 
MCPyV sT (Fig. 4.5B). Ctrl or sT whole cell lysates (WCL) were collected for NoShift 
assay. Binding reactions were set up so that the Ori oligos, LT NE, and increasing 
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amount of either sT or ctrl WCL were incubated together. Although the signals were 
slightly higher in the presence of additional WCL, they were neither dose-dependent on 
the amount of WCL added nor were they specifically increased in the presence of sT 
WCL (Fig. 4.5B). It is noted that some background from sT WCL was seen regardless of 
the presence of the Ori oligos, suggesting that the background did not result from sT 
binding to the Ori (Fig. 4.5B, compare “No Ori + 4x WCL” and “Ori + 4x WCL”).  
 As mentioned before, since there is no OBD on sT, it is not expected that sT 
would bind to the Ori. My data from Fig. 4.5B also supports this idea. Nonetheless, I 
performed a NoShift assay in which the Ori oligos were only incubated with increasing 
amount of sT WCL, without the addition of LT NE (data not shown). The signals 
detected were not significantly above background and they were not dose-dependent. To 
ensure that the detection of the potential sT/Ori binding signal was not limited by the 
amount of sT present in the WCL, similar NoShift experiments were performed with sT 
expressed in and purified from E. coli (data not shown). Again, no clear binding signal 
was detected. In sum, the NoShift data show that this is an efficient assay to test for LT 
binding to the Ori. However, sT does not affect the affinity of LT for the Ori nor does it 
bind to the Ori itself. Therefore, the mechanisms by which sT contributes to LT-mediated 
viral DNA replication at the replication complexes require furtuer investigation.  
 
4.6: MCPyV sT Oligomerization 
 As described in the Introduction, during polyomavirus replication, LT recognizes 
and binds to the pentanuclotides in the Ori, oligomerizes to form hexamers, and 
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consequently unwinds the dsDNA viral genome. However, it is remains unclear how sT 
contributes to viral replication directly. While I was performing co-immunoprecipitation 
experiments to test for MCPyV LT and sT interaction, I also investigated if sT can 
interact with itself, which might provide important insight into the mechiasms by which 
this protein functions.  
 I transfected HEK293 cells with a plasmid encoding IIT-tagged MCPyV sT and 
either the vector control or a plasmid encoding untagged sT (Fig. 4.6). Purification of 
IIT-sT using IgG beads was efficient (Fig. 4.6, “IP”). Interestingly, I also detected the 
pulldown of untagged sT, suggesting that IIT-sT interacts with untagged sT, either 
forming dimers or oligomers. Preliminary data from Dr. Ranran Wang of our lab supports 
the notion that sT might oligomerize: Purified sT complex is large and migrate slowly in 
native gels (data not shown). This is an interesting feature of MCPyV sT that requires 
further studies to delineate the importance of oligomerization for sT’s functions.  
 
4.7: Discussion 
In this chapter, I present structural modeling and in vivo 55Fe labeling data to 
support that MCPyV sT expressed in mammalian cells coordinates Fe/S clusters, as 
demonstated by the EPR analysis on sT expressed in bacteria (see Chapter 3). This novel 
finding leads us to investigate what role the Fe/S clusters play in sT’s functions.  
 Based on what is known about the mammalian Fe/S cluster protein XPD, it is 
hypothesized that the Fe/S cluster of the helicase functions as a molecular “plowshare” to 
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separate the DNA duplex as ssDNA is drawn through (125, 129). Therefore, I have 
performed various helicase and unwinding assays to test if MCPyV sT could act as a 
“plowshare” on its own or affect LT’s ability to unwind dsDNA (data not shown). 
However, none of my experiments have shown much of sT’s effect to ascribe such role to 
the Fe/S clusters in sT. Nonetheless, it is evident that the cysteine mutations in sT affect, 
to varying degree, the protein stability/expression (see Chapter 3), suggesting that the 
Fe/S clusters are at least important for proper folding of the sT protein. 
 Beyond playing a structural role, the functions, if any, of the Fe/S clusters in sT 
remain elusive. One interesting hypothesis is that the iron in the sT Fe/S clusters forming 
reactive oxygen species via the Fenton reaction and, consequently, oxidizing DNA and 
generating DNA breaks (186). In such scenario, sT could act as a topoisomerase to 
release DNA tension during viral replication. MCPyV LT-mediated in vitro replication 
experiments would allow us to test if the topology of replicated viral DNA is affected by 
the presence of sT. 
 The mechanisms by which MCPyV sT is recruited to the sites of viral replication 
require further investigation since my data presented in this chapter show no interaction 
between sT and LT or between sT and the viral Ori. However, it is plausible that sT is 
recruited by interacting with DDR factors that are part of the replication complex (see 
Chapter 2). In addition, in the transgenic mouse model, sT expression is associated with 
the DDR activation marker γH2AX (43). Whether DDR factors mediate sT recruitment to 
the viral DNA replication complex remains to be tested. Immunoprecipitation 
experiments, coupled with mass spectrometry, are required to identify other cellular 
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binding partners of sT. Results from these experiments would allow us to identify 
candicates that could contribute to viral replication while mediating sT recruitment to the 
sites of replication.  
 
4.8: Figures 
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Figure 4.1 
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Figure 4.1   Modeling of MCPyV sT structure. The MCPyV sT sequence was obtained 
from NCBI and its structure was modeled using Phyre2 and PyMOL. The three cysteines 
in the CA cluster are labeled in green and those in the CF cluster are labeled in red. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   111	  
Figure 4.2 
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Figure 4.2   Association of 55Fe in MCPyV sT expressed in mammalian cells. 
HEK293 cells were transfected with either the vector control (Vec) or a plasmid carrying 
sT-TII (sT). At 12 hpt, transfection reagent was washed off and fresh culture media, 
supplemented with 50 µM DFO, was added to chelate iron in the media. At 28 hpt, DFO 
was washed off and fresh culture media, supplemented with 1 µM 55Fe, was added to the 
cells. At 50 hpt, cells were harvested and lysed by sonication. Whole cell lysates were 
incubated with IgG beads for two hours. Unbound proteins were washed off before the 
addition of sample buffer to the beads. (A) The 55Fe signal from two-thirds of the purified 
proteins was measured by liquid scintillation counting. Data represent means and the 
standard error of the mean from three experiments. (B) One-thirds of the purified proteins 
was resolved on SDS-PAGE to confirm sT immunoprecipitation by western blotting. 
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Figure 4.3 
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Figure 4.3   Effects of FBS depletion on MCPyV LT-mediated viral DNA replication 
in the absence and presence of sT. (A) C33A cells were co-transfected with a plasmid 
encoding MCPyV LT, a plasmid carrying the MCPyV Ori, and either the vector control 
(Vec) or wild-type sT (sT). At 24 hpt, transfection reagent was washed off and complete 
culture media was added to the culture, which was replaced with culture media without 
FBS for various amount of time as indicated. At 48 hpt, total cellular DNA was extracted 
for Southern blotting. A total of 15 ug of DNA was digested with BamHI and DpnI to 
detect newly-replicated DNA, while 2 ug of DNA was digested with only BamHI to 
show equal loading. (B) Total protein extractions were used in western blotting to detect 
MCPyV LT, sT, and actin. 
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Figure 4.4 
 
Figure 4.4   MCPyV LT and sT do not physically interact with each other. (A) 
HEK293 cells were co-transfected with a plasmid encoding IIT-tagged MCPyV LT and 
either the empty vector control or wild-type sT (sT). At 48 hpt, cells were harvested and 
lysed for co-immunoprecipitation. Nuclear extracts were incubated with IgG beads for 
four hours. The MCPyV Ori plasmid or the vector control was added during incubation to 
recapitulate the formation of replication complexes. Unbound proteins were washed off 
the beads. Tobacco etch virus (TEV) protease was used to cleave LT off the beads and to 
collect LT and its associated complexes. Purified proteins were resolved on SDS-PAGE 
and blotted for LT and sT using the 2t2 antibody, which recognizes the common DnaJ 
domain of the T antigens.  
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Figure 4.5 
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Figure 4.5 Binding of MCPyV LT to the viral Ori in the presence of sT. (A) HEK293 
cells were transfected with a vector control (ctrl) or a plasmid encoding MCPyV LT. At 
48 hpt, cells were harvested for NoShift assay. Nuclear extracts (NE) were desalted prior 
to the assay to allow for protein/oligo binding. Different binding reactions were set up as 
labeled in the X-axis. The CM2B4 antibody was used to detect LT bound to the oilgos. 
Representative data from two experiments are shown. (B) HEK293 cells were transfected 
with a vector control (ctrl) or a plasmid encoding MCPyV sT. At 48 hpt, whole cell 
lysates (WCL) were collected for NoShift assay. LT NE was prepared as described in 
panel A. Both LT and sT protein extracts were desalted prior to the assay to allow for 
protein/oligo binding. Different binding reactions were set up as labeled in the X-axis. 
The CM2B4 antibody was used to detect LT bound to the oilgos. Representative data 
from two experiments are shown. 
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Figure 4.6 
 
 
Figure 4.6   MCPyV sT interacts with itself to form oligomers. (A) HEK293 cells 
were co-transfected with a plasmid encoding IIT-tagged MCPyV sT and either the empty 
vector control or untagged sT. At 48 hpt, cells were harvested and lysed for co-
immunoprecipitation. Nuclear extracts were incubated with IgG beads for four hours. 
Unbound proteins were washed off before the addition of sample buffer. Purified proteins 
were resolved on SDS-PAGE and blotted for sT. 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 
5.1: Merkel Cell Polyomavirus Replication and the Host DNA Damage Response 
MCPyV is associated with a highly aggressive form of skin cancer in humans (6). 
Epidemiological surveys for MCPyV seropositivity and sequencing analyses of healthy 
human skin suggest that MCPyV may represent a common component of the human skin 
microbial flora (55, 147). However, much of the biology of the virus and its oncogenic 
ability remain poorly understood. My thesis focuses on the study of the MCPyV early 
proteins, LT and sT, with an overarching emphasis on their roles in viral replication.  
In Chapter 2, I show that, in cells infected with native MCPyV virions, 
components of the ATM- and ATR-mediated DDR pathways accumulate in MCPyV LT-
positive nuclear foci (Fig. 2.1). This is the first visualization of cells infected with native 
MCPyV, clearly showing the nuclear foci, which I later proved to be the viral replication 
factories in the host (see below). Ongoing research on the identification of MCPyV 
natural host cell done by Dr. Wei Liu in our lab has subsequently confirms this 
observation (unpublished data). Such a phenotype was recapitulated using our previously 
established LT/Ori co-transfection system for visualizing MCPyV replication complexes 
in cells (Fig. 2.3 and 2.4, (104)). The consistent observation of the host DDR machinery 
localizing at the sites of viral replication in both the natural infection system and in the 
LT/Ori co-transfection system gave us confidence that our replication system in cultured 
cells serves as a good platform for the study of MCPyV replication. However, it is 
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essential to study how an activated DDR in the host contributes to viral replication in the 
natural infection setting once such a system becomes feasible. 
By combining fluorescence in situ hybridization and BrdU incorporation analysis, 
I demonstrate that the nuclear foci observed are authentic sites of active viral replication 
(Fig. 2.6). This conclusion is reinforced by additional evidence using helicase-defective 
LT mutants and replication-defective Ori, showing the lack of nuclear foci (Fig. 2.7). In 
addition, I also show that the inhibition of DDR pathways using chemical inhibitors or 
siRNA knockdown negatively affects MCPyV replication, suggesting that both ATM and 
ATR pathways are functionally important for efficient viral replication (Fig. 2.8 and 2.9). 
My study presented in Chapter 2 provides the first look into the microscopic 
details of DDR factor/LT replication complexes at the MCPyV origin. It also provides a 
platform for studying other host machinery required for MCPyV replication. As briefly 
described in the Introduction, there are numerous host proteins that are involved in 
different arms of the DDR. Whether they localize at the sites of MCPyV replication and 
contribute to the process remain to be tested. While it is possible to test them 
individually, it would be more efficient to perform reverse chromatin 
immunoprecipitation coupled with mass spectrometry, which would allow for the 
isolation and identification of protein complexes found at the viral Ori. This technique 
could provide valuable insight into the cellular factors involved in MCPyV replication.  
The association of the host DDR and viral infections is undeniable. However, in 
many cases, how viruses interact with these pathways and/or the precise reasons for the 
interactions remain unclear. For polyomaviruses, it is hypothesized that virus-induced 
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activation of DDR can help repair DNA lesions caused by the infection and that DDR-
mediated checkpoint signaling helps arrest the host cell cycle in S/G2 phase, creating a 
cellular environment condusive for viral replication (106, 108, 109). Previous research 
done by our lab supports this notion since MCPyV LT expression also causes a modest 
G2 arrest (39).  
Additionally, our lab has recently identified a novel phosphorylation site in the C-
terminus of LT at serine 816 (S816), which, with in vitro phosphorylation experiments, 
was shown to be phosphorylated by ATM (40). S816 phosphorylation induces apoptosis 
in the host, suggesting that it may contribute to the MCPyV LT C-terminal domain’s anti-
tumorigenic properties, as documented previously (34, 39). We have yet to investigate 
whether this ATM-mediated modification regulates other functions of LT. Furthermore, it 
is unknown whether the other MCPyV early proteins are also modified/regulated by the 
host DDR. Such studies would shed light on the mechanistic role of host DDR factors in 
the MCPyV life cycle and virus-associated oncogenesis. 
 
5.2: Merkel Cell Polyomavirus Small Tumor Antigen as an Fe/S Cluster Protein and 
Its Potential as a Drug Target 
5.2.1: MCPyV sT is a novel Fe/S cluster protein and its implication in viral replication 
 To fully understand MCPyV biology, it is necessary to study how the viral 
proteins cooperate with each other to complete the viral life cycle. While Chapter 2 of my 
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thesis focuses on LT-mediated replication, Chapter 3 and 4 highlight the other early 
protein, sT, and addresses the effects it has on viral replication.  
In Chapter 3, I show evidence that MCPyV sT expressed in and purified from 
bacteria is an Fe/S cluster protein (Fig. 3.1, 3.2, and 3.4). EPR analysis on sT definitely 
shows the coordination of a binuclear cluster by the CA cluster (C119, C121, and C124), 
and another tetranuclear cluster coordinated by the CF cluster (C147, C149, and C152) 
(Fig. 3.4). The structural modeling presented in Fig. 4.1 shows that the three cysteines in 
each of the cluster point toward each other to form pocket-like structures. Ongoing effort 
in crystallizing this protein would help demonstrate the structural detail in the 
coordination of these clusters.  
This is the first report identifying MCPyV sT as an Fe/S cluster protein. While I 
subsequently show similar Fe/S cluster protein characteristics exhibited by other 
polyomaviruses’ sTs, MCPyV sT’s coordination of the Fe/S clusters is comparatively 
more stable (Fig. 3.8). This finding adds to the uniqueness of MCPyV and may provide 
important clues for understanding the functional difference between MCPyV sT and 
other polyomaviruses’ sTs. 
A major obstacle in the Fe/S cluster field is the technical limitation of detecting 
Fe/S clusters in proteins expressed in mammalian cells, which leaves some critics 
question whether the Fe/S clusters detected by EPR are solely an artifact of over-
expressing a protein of interest in bacteria. However, an efficient 55Fe labeling protocol 
for Fe/S clusters has not yet been described for mammalian cell culture system (187). In 
Chapter 4, I present a method for 55Fe labeling in HEK293 cells expressing MCPyV sT, 
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followed by purification of MCPyV sT and the measurement of incorporated 55Fe signal 
by liquid scintillation counting (Fig. 4.2). As noted earlier, the caveat of this procedure is 
that I cannot rule out possible cellular binding parters of sT being Fe/S cluster proteins. 
Nonetheless, the combination of the EPR analysis (Fig. 3.1, 3.2, and 3.4) and this 
additional piece of evidence from mammalian cell culture system (Fig. 4.2) give us 
confidence to believe that MCPyV sT is an Fe/S cluster protein.  
To better understand the functional importance of the Fe/S clusters in MCPyV sT, 
various cysteine mutations were generated to test for their effects on sT’s ability to 
enhance LT-mediated replication (Fig. 3.3). My result shows that the conserved cysteine 
clusters are important for sT’s ability to stimulate viral replication (Fig. 3.5). I also 
present immunofluoresence data that suggests a more direct role of sT in replication (Fig. 
3.6). Although I had performed various experiments in attempt to understand the how sT 
directly contributes to LT-mediated MCPyV replication (Chapter 4 and data not shown), 
I was unable to provide a mechanistic explanation for the phenotype I observed. Perhaps 
extending investigation on sT’s effect on DNA elogation and/or DNA polymerase 
processivity would provide new clues for understanding the role(s) of the sT Fe/S clusters 
in the context of viral replication.  
 
5.2.2: MCPyV sT as a potential drug target  
 Previous research has shown that cidofovir is a potent inhibitor of polyomavirus 
replication (169, 170, 178). It is hypothesized that cidofovir acts as a competitive 
inhibitor to natural nucleotide substrates and gets incorporated into the newly synthesized 
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DNA chain, eventually leading to DNA chain termination (168). Although the recent case 
study on MCPyV-associated Stevens-Johnson Syndrome, in which the high viral load of 
MCPyV in the patient was cleared after cidofovir treatment, gives us hint as to the 
efficacy of cidofovir as a drug to control MCPyV (171), it lacks biochemical evidence to 
explain why MCPyV was cleared. 
My result in Fig. 3.7 shows that cidofovir robustly inhibits sT-mediated 
enhancement of viral replication but has minimal effect on the basal MCPyV replication 
driven by LT alone. The fact that sT sensitizes viral replication to cidofovir treatment 
suggests that sT is a potential drug target for dampening MCPyV infection. However, 
additional biochemical studies are needed to delineate the exact mechanism of action for 
the cidofovir-mediated inhibition of viral replication. Fortunately, the company Chimerix 
Inc. took interest in my cidofovir data, and has offered to supply various modified 
versions of cidofovir for our lab to continue studying how this drug is effective against 
MCPyV replication. 
 
5.3: Current Obstacles in Merkel Cell Polyomavirus Research 
 The discovery of MCPyV and its association with MCC has opened new doors for 
us to understand the oncogenic potential of polyomaviruses. Nevertheless, research on 
MCPyV is still at a very early stage. Much of what we known is drawn from decades of 
studies on SV40. However, research in this field, including what has been described in 
my thesis, is showing some differences among polyomavirses. 
	   125	  
One major setback in the study of MCPyV biology is the lack of a viable cell 
culture system for propagating the virus, making it difficult to use natural infection to 
study the viral life cycle. Although our lab has been relying on transient expression of the 
viral proteins to investigate different aspects of MCPyV biology, we are now focusing on 
identifying the natural host cells of MCPyV in the skin and establishing a system in 
which the virus can propagate. Such a system would allow us to perform experiments in a 
more physiological setting and to better understand the roles of each viral protein, 
including 57kT and ALTO, in MCPyV life cycle. 
 
5.4: Concluding Remarks 
 Since its discovery in 2008, MCPyV has rejuvenated the interest in studying the 
association between polyomaviruses and human cancers. My thesis work has explored 
the roles of the viral early proteins LT and sT in the context of viral replication. In 
addition to identifying a number of host DDR factors important for efficient MCPyV 
replication, my discovery that sT is an Fe/S cluster protein also sheds new light on the 
structure and function of this important viral protein. Furthermore, my study highlights 
sT as a good drug target for dampening viral replication. Ongoing effort in setting up a 
physiological cell culture system for MCPyV infection will be a great asset to the field. 
Future work exploring how all the MCPyV early proteins coordinate to establish a latent 
infection in the host will be essential to our understanding of MCPyV-associated MCC 
oncogenesis. 
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CHAPTER 6: MATERIALS AND METHODS 
 
6.1: Cell Culture, Cell Lines, and DNA/siRNA Transfection 
U2OS cells were maintained in McCoy's 5A medium (Invitrogen) containing 10% 
fetal bovine serum (HyClone). C33A cervical carcinoma cells and HEK293 cells were 
maintained in Dulbecco modified Eagle medium (Invitrogen) containing 10% fetal 
bovine serum. For immunofluorescent staining, C33A cells were transfected at 40 to 50% 
confluence using the FuGENE6 transfection reagent (Promega) according to the 
manufacturer's instructions, and fixed at 48 to 60 h post-transfection (hpt). For Southern 
blotting and flow cytometry analysis, C33A cells were transfected using the calcium 
phosphate method (188). Small interfering RNA (siRNA) transfection was performed 
using calcium phosphate, as previously described (160). To detect viral DNA replication, 
C33A cells were pulsed with 10 µM BrdU at 44 hpt for 2 h and cultured with normal 
growth medium for another 2 h before acetone fixation. 
 
6.2: Recombinant Plasmid Construction 
Plasmids used including religated MCPyV genome, pcDNA4C-MCPyV LT, 
pcDNA4C-MCPyV Ori, pADL*, pT+Ori, pwM (MCPyV VP1), and pMMt (MBP-
MCPyV sT) have been previously described (55, 56, 104). The origin mutant Ori350 was 
constructed from pcDNA4C-MCPyV Ori by site-directed mutagenesis. The plasmid 
pMtw was generated by moving an sT ORF carrying a silent mutation in the LT major 
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splice donor (from plasmid pMtBS (56)) into pwM, replacing the VP1 ORF. Plasmid 
maps are posted online http://home.ccr.cancer.gov/Lco/. All MCPyV sT mutants were 
modified from pMMt and pMtw using site-directed mutagenesis. Plasmid pMBP-SV40sT 
encoding MBP-SV40 sT was made by PCR amplification of SV40 sT from pMIG-SV40 
sT (Addgene), followed by digestion with SacI and XhoI to replace MCPyV sT in pMMt. 
The plasmids pMe1t (MBP-HPyV6 sT) and pMe2t (MBP-HPyV7 sT) were generated by 
cloning PCR products into the SacI-PstI sites of pMXB10 (NEB). For generating the 
construct encoding MCPyV sT fused to two IgG binding domains of Staphylococcus 
aureus protein A through a tobacco etch virus (TEV) protease cleavage site (sT-TII), 
PCR-amplified coding DNA fragment was cloned into pMtw using the Mlu I and EcoR V 
sites. 
 
6.3: Recombinant Protein Production 
BL21(DE3)pLysS competent cells (Promega) were transformed with plasmids as 
indicated in the figure legends. Bacterial cultures were grown in 2xYT medium to 
A600~0.6 before 0.4 mM IPTG induction at 37oC for 4 h. Bacteria were collected and sT 
purification was performed using solutions that were degassed and purged with oxygen-
free nitrogen. The cells were lysed with column buffer (20 mM Tris-HCl [pH 7.4], 200 
mM NaCl, 1 mM DTT, 1 mM EDTA, 10 mM MgCl2, 10% glycerol, 20 ug/ml DNase, 
0.4 mg/ml lysozyme, supplemented with protease inhibitors) before incubation with 
amylose resin (NEB) at 4oC for 2 h. The resin was then washed five times with wash 
buffer (20 mM Tris-HCl [pH 7.4], 200 mM NaCl, 1 mM DTT, 1 mM EDTA, 10% 
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glycerol, supplemented with protease inhibitors) before elution with the same buffer with 
an addition of 10 mM maltose. The eluted proteins were concentrated using centricon 
(Millipore). 
 
6.4: Electron Paramagnetic Resonance (EPR) Spectroscopy 
EPR samples were prepared under strict anaerobic conditions on the same day 
after MCPyV sT proteins were isolated. MCPyV sT proteins were reduced with 20 mM 
of anaerobically prepared neutralized sodium dithionite and incubated at room 
temperature for 10 min. Then, the protein samples were transferred to EPR tubes, quickly 
frozen in a dry ice-ethanol mixture, and were stored in liquid nitrogen until EPR analyses. 
EPR spectra were recorded by a Bruker Elexsys E500 spectrometer at X-band (9.4 GHz) 
using an Oxford Instrument ESR900 helium flow cryostat. EPR spectra of the Fe/S 
cluster signals were simulated by SimFonia (Bruker, Germany) and Easyspin 
(http://www.easyspin.org).  
 
6.5: Antibodies, Chemicals, and siRNAs 
The following antibodies were used for immunofluorescent staining: mouse anti-
MCPyV LT (CM2B4; Santa Cruz), goat anti-ATR (N-19; Santa Cruz), rabbit anti-
pChk1S317 (Cell Signaling), rabbit anti-pATMS1981 (Cell Signaling), rabbit anti-pChk2T68 
(Cell Signaling), rabbit anti-Nbs1 (Novus Biologicals), rabbit anti-pRPA32S33 (Bethyl 
Laboratories), rabbit anti-RPA70 (Cell Signaling), mouse anti-Ki-67 (Dako), mouse anti-
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Xpress (Invitrogen), Alexa Fluor 594 goat anti-rabbit IgG (Invitrogen), Alexa Fluor 594 
donkey anti-goat IgG (Invitrogen), and Alexa Fluor 488 donkey anti-mouse IgG 
(Invitrogen).  
The following antibodies were used for western blotting: mouse anti-MCPyV LT 
(CM2B4; Santa Cruz), mouse anti-MCPyV LT/sT J-domain 2t2 (104), rabbit anti-ATM 
(Cell Signaling), rabbit anti-ATR (Abcam), mouse anti-actin (Chemicon), horseradish 
peroxidase (HRP)-conjugated donkey anti-mouse (Cell Signaling), and HRP-conjugated 
donkey anti-rabbit (Cell Signaling). Western Lightning Plus ECL solution was purchased 
from PerkinElmer. SuperSignal West Pico Chemiluminescent Substrate solution was 
purchased from Thermo Scientific.  
Wortmannin and NU6027 were purchased from Sigma and dissolved in dimethyl 
sulfoxide (DMSO). Deferoxamine and 55Fe were provided by the courtesy of Dr. Andrew 
Dancis (University of Pennsylvania). Cidofovir was purchased from Sigma and dissolved 
in water. Control siRNA and siRNA pools targeting human ATR and ATM were 
purchased from Dharmacon and used as previously described (108). 
 
6.6: MCPyV Virion Preparation and Infection 
Native MCPyV and MCPyV pseudoviruses were prepared as previously 
described (56), with minor modifications. Briefly, an initial seed stock of native virions 
was produced by transfecting 293-4T cells (which stably express the MCPyV LT and sT 
proteins) with the religated recombinant genome of MCPyV isolate R17b (11, 54, 179). 
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Five days later, native MCPyV virions were harvested and purified over an OptiPrep 
gradient. This initial seed stock of native MCPyV virions was used to infect fresh 293-4T 
cells. The MCPyV-infected 293-4T cells were harvested and lysed after 5 days of 
infection, and the amplified native MCPyV virions were purified over an OptiPrep 
gradient. For experimental infection, U2OS cells were seeded in 24-well plates and 
incubated with native MCPyV virions at a dose of 5x104 MCPyV genomes per cell for 5 
days. 
 
6.7: Immunofluorescent Staining 
Immunofluorescent staining was performed as previously described (104). C33A 
cells were fixed with 3% paraformaldehyde in phosphate-buffered saline (PBS) for 20 
min. Cells were incubated in blocking/permeabilization buffer (0.5% Triton X-100 and 
3% bovine serum albumin in PBS) for 10 min at room temperature and stained with 
primary antibodies (as indicated in the appropriate figure legends) at room temperature 
for 1 h. Cells were washed three times with blocking/permeabilization buffer and 
incubated with secondary antibodies for an additional hour. Cells were then 
counterstained with DAPI (4′,6′-diamidino-2-phenylindole) and examined with an 
Olympus IX81 inverted fluorescence microscope. 
 
6.8: Immuno-FISH 
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Immuno-FISH was performed as previously described (104), with slight 
modifications. Briefly, C33A cells were fixed and stained using antibodies as indicated in 
the appropriate figure legends. A specific probe recognizing pcDNA4C-MCPyV Ori and 
a negative-control probe recognizing the human papillomavirus type 16 (HPV16) genome 
were labeled with biotin-dUTP (AppliChem) using nick translation. Hybridized probes 
were detected with a TSA biotin system (PerkinElmer) following the manufacturer's 
instruction. 
 
6.9: Microscropy and Image Analysis 
All immunofluorescent images were collected using an inverted fluorescence 
microscope (IX81; Olympus) connected to a high-resolution charge-coupled-device 
camera (FAST1394; QImaging). Images were analyzed and presented using SlideBook 
(version 5.0) software (Intelligent Imaging Innovations, Inc.). The scale bars were added 
using ImageJ software. 
 
6.10: Southern Blotting 
Southern blotting was performed as previously described (104), with slight 
modification. For DDR inhibitor treatment, C33A cells were incubated at 20 hpt in 
medium with 20 µM wortmannin or 20 µM NU6027. Drugs were refreshed every 16 h, 
and cells were harvested at 52 hpt. For ATR/ATM knockdown, pT+Ori and siRNA were 
transfected at the same time using calcium phosphate. About 30 µg total DNA was 
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digested with DpnI and XhoI, before being subjected to Southern blotting, while 2 µg 
total DNA was digested with XhoI and used as a loading control. 
For cidofovir treatment, C33A cells were incubated at 24 hpt in media containing 
different doses of cidofovir as indicated. Cells were harvested at 48 hpt. About 15 µg 
total DNA was digested with DpnI and BamHI before being subjected to Southern 
blotting, while 2 µg total DNA was digested with BamHI and used as loading control. 
The phosphor screen was scanned with Typhoon FLA 7000 (GE Healthcare Life 
Sciences) and the data was quantified with ImageQuant TL software (GE Healthcare Life 
Sciences). 
 
6.11: Western Blotting 
Cells were lysed in lysis buffer (10 mM HEPES [pH 7.9], 500 mM NaCl, 3 mM 
MgCl2, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride) by passing through a 
22-gauge needle 10 times. After a 30 min incubation on ice, the soluble and insoluble 
fractions were separated by centrifugation at 15,000 rpm for 5 min at 4°C. The 
supernatants (20-30 µg) were resolved on an SDS-polyacrylamide gel. Membranes were 
blotted according to the antibody manufacturers' instructions. Western blots were 
developed using enhanced chemiluminescence (ECL) solution, and images were captured 
using a Fuji imaging system. 
 
6.12: Flow Cytometry 
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C33A cells were pulse labeled with 10 µM BrdU for 2 h before trypsinization. 
They were then fixed, permeabilized, and stained using an allophycocyanin BrdU flow 
kit (BD Pharmingen) according to the manufacturer's instructions. Stained cells were 
analyzed by flow cytometry using a BD FACSCalibur flow cytometer (Becton, 
Dickinson). Data were analyzed using FlowJo software. 
 
6.13: 55Fe Labeling in Mammalian Cells 
HEK293 cells were transfected with the indicated plasmids using the calcium 
phosphate method. At 12 hpt, cells were washed three times with DMEM to remove 
transfection reagents. Fresh culture media (DMEM with 10% FBS), supplemented with 
50 µM desferoxamine (DFO, Ciba Geigy Corp.), was then added to chelate iron in the 
media. At 28 hpt, cells were washed three times with DMEM to remove DFO. Fresh 
culture media (DMEM with 10% FBS), supplemented with 1 µM 55Fe (Cyclotron Co. 
Ltd, Obninsk, Russia. Specific activity ~ 100 mCi/mg), was added to the cells. At 50 hpt, 
cells were harvested and lysed by sonication in resuspension buffer (20 mM HEPES [pH 
7.5], 150 mM NaCl, supplemented with protease inhibitors). Whole cell lysates were 
incubated with IgG beads (GE Healthcare) for 2 h at 4oC. Unbound proteins were washed 
away with wash buffer (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% NP-40, 
supplemented with protease inhibitors) before the addition of sample buffer to the beads. 
The 55Fe signal from two-thirds of the purified protein sample was measured by liquid 
scintillation counting (Beckman LS 6500). 
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6.14: Co-Immunoprecipitation 
 HEK293 cells were transfected as indicated in the figure legends using the 
calcium phosphate method. At 48 hpt, cells were harvested and resuspended in buffer A 
(10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, supplemented with protease 
inhibitors). After 10 min incubation on ice, 0.5% NP-40 was added to the lysate. 
Supernatant was removed and nuclear pellet was resuspended in buffer B (20 mM 
HEPES [pH 7.9], 400 mM NaCl, 1mM EDTA, supplemented with protease inhibitors). 
The nuclei were lysed by passing the pellet suspension through a 22-gauge needle about 
15 times, followed by incubation at 4 oC for 1 h. Debris was removed and nuclear 
extracts were incubated with IgG beads (GE Healthcare) for 4 h at 4oC. Unbound proteins 
were washed away with wash buffer (10mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% 
NP-40, supplemented with protease inhibitors).  
 For TEV cleavage, the IgG beads were resuspended in TEV cleavage buffer 
(10mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% NP-40, 0.5 mM EDTA, 1 mM DTT) 
containing TEV enzyme (Invitrogen) at the final concentration of 0.8 U/ul. Cleavage 
reactions were incubated at room temperature for 2 h. The supernatant with the purified 
protein complexes was then resolved by SDS-PAGE.  
 
6.15: NoShift Assay 
 The following Ori oligos, with 3’-ends labeled with biotin, were used: 5’-
TTTTTTTTCAAGTTGGCAGAGGCTTGGGGCTCCTAGCCTCCGAGGCCTCTGGA
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AAAAAAAGAGAGAGGCCTCTGAGGCTTAAGAGGCTTA-3’ and 5’-
TAAGCCTCTTAAGCCTCAGAGGCCTCTCTCTTTTTTTTCCAGAGGCCTCGGAG
GCTAGGAGCCCCAAGCCTCTGCCAACTTGAAAAAAAA-3’. The oligos were 
annealed according to the instructions of NoShift Transcription Factor Assay Kit 
(Novagen). LT nuclear extract was prepared as described in Section 6.14 and sT whole 
cell lysate was prepared as described in Section 6.13. Both nuclear and whole cell lysates 
were desalted using the PD SpinTrap G-25 columns (GE Healthcare). Binding reactions 
were prepared as indicated in the figure. The NoShift assay was performed according to 
the manufacturer's instructions. The CM2B4 antibody was used to detect LT bound to the 
oligos.  
 
6.16: Statistical Analysis 
Statistical analysis was performed using one-way analysis of variance with 
GraphPad Prism software (version 5.0). A P value of <0.05 was considered statistically 
significant. 
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